醫師學術論文
Paper鄭隆賓 Long-Bin Jeng 器官移植中心榮譽院長、細胞治療中心榮譽主任、肝癌團隊負責人
國內媒體曾報導國內肝臟移植三大名醫「北伯皇、中隆賓、南肇隆」的美譽,三人都師承美國換肝權威史達哲 (Dr. Starzl),三位師兄弟各有特色,各自闖出一片天。如今台大李伯皇教授即將退休,而鄭隆賓院長正帶領本院器官移植中心更燦爛輝煌的未來。鄭院長不僅在肝臟移植領域表現卓越,同時也是一位優秀的肝膽腸胃和甲狀腺腫瘤執刀的外科權威。在本院器官移植中心,鄭院長扮演功不可滅的創基角色
學術機構典藏
論文
期刊論文
期刊論文/Journal Paper (作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄) |
日期 | |
1 | 許斐婷(Hsu, Fei-Ting)、陳映慈(Ying-Tzu Chen)、金育誠(Yu-Cheng Chin)、張立展(Li-Chan Chang)、江菽瑾(Shu-Chin Chiang)、楊理行(Li-Xing Yang)、劉華姍(Hua-Shan Liu)、樂柏甫(Po-Fu Yueh)、涂熊林(Hsiung-Lin Tu)、(Ruei-Yu He)、鄭隆賓(Long-Bin Jeng)、徐偉成(Woei-Cheang Shyu)、胡尚秀(Shang-Hsiu Hu)、蔣宜蒼(I-Tsang Chiang)、劉育昌(Yu-Chang Liu)、(Yi-Chun Chiu)、(Guan-Chun Wu)、游景晴(Ching-Ching Yu)、蘇文彬(Wen-Pin Su)*、黃志嘉(Chih-Chia Huang)*,Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against Glioblastoma and Pancreatic Cancer,ACS Nano,2024 Oct,18(42):28764-28781 | 2024 . 10 |
2 | (Chie-Hong Wang)、(Guan-Cyun Lin)、傅如輝(Ru-Huei Fu)、黃毓銓(Huang, Yu-Chuen)、陳世殷(Shih-Yin Chen)、(Shinn-Zong Lin)、(Horng-Jyh Harn)、徐偉成(Woei-Cheang Shyu)、(Yi?Fang Huang)、鄭隆賓(Long-Bin Jeng)、劉詩平(Shih-Ping Liu)*,Neural stem cells derived from α-synuclein-knockdown iPS cells alleviate Parkinson’s disease,Cell Death Discovery,2024 Sep,10(1):407-416 | 2024 . 09 |
3 | 李瑋(Wei Lee)、林瑄翎(Lin Syuan-Ling)、江智聖(CHIANG, CHIH-SHENG)、陳睿妤(CHEN JUI-YU)、錢韋薇(Wee-Wei Chieng)、黃淑柔(Shu-Rou Huang)、張庭毓(CHANG TING-YU)、(B. Linju Yen)、洪明奇(Mien-Chie Hung)、張坤正(Kuan-Cheng Chang)*、(Hsu-Tung Lee)*、鄭隆賓(Long-Bin Jeng)*、徐偉成(Woei-Cheang Shyu)*,Role of HIF-1α-activated IL-22/IL-22R1/Bmi1 Signaling Modulates the Self-renewal of Cardiac Stem Cells in Acute Myocardial Ischemia,Stem Cell Reviews and Reports,2024 Aug,xx(xx):xx-xx | 2024 . 08 |
4 | 林瑄翎(Lin Syuan-Ling)、張怡雯、李瑋(Wei Lee)、江智聖(CHIANG, CHIH-SHENG)、劉詩平(Shih-Ping Liu)、(Hsu-Tung Lee)*、鄭隆賓(Long-Bin Jeng)*、徐偉成(Woei-Cheang Shyu)*,Role of STAT3-FOXO3 Signaling in the Modulation of Neuroplasticity by PD-L1-HGF-Decorated Mesenchymal Stem Cell-Derived Exosomes in a Murine Stroke Model,Advanced Science,2024 Jul,25(e2404882): | 2024 . 07 |
5 | (Hung-Wei Cheng)、李瑋(Wei Lee)、許斐婷(Hsu, Fei-Ting)、賴彥合(LAI YEN-HO)、黃淑柔、(Chris Seh Hong Lim)、(Zhen-Kai Lin)、許士超(Shih-Chao Hsu)、江智聖(CHIANG, CHIH-SHENG)*、鄭隆賓(Long-Bin Jeng)*、徐偉成(Woei-Cheang Shyu)*、陳三元*,Manipulating the Crosstalk between Cancer and Immunosuppressive Cells with Phototherapeutic Gold-Nanohut for Reprogramming Tumor Microenvironment,Advanced Science,2024 Jun,-(-): | 2024 . 06 |
6 | 王淑瑩(Shu-Ying Wang)、鄭隆賓(Long-Bin Jeng)、楊宏仁(Horng-Ren Yang)、葉俊杰(Yeh, Chun-Chieh)*,Rare causes of recurrent cholangitis after hepaticojejunostomy: A case series,Asian Journal of Surgery,2024 May,47(5):2540-2541 | 2024 . 05 |
7 | 賴香君(Hsiang-Chun Lai)、鄭如茜(Ju Chien Cheng)、葉晞彤(YIP HEI-TUNG)、鄭隆賓(Long-Bin Jeng)、黃升騰(Sheng-Teng Huang)*,Chinese herbal medicine decreases incidence of hepatocellular carcinoma in diabetes mellitus patients with regular insulin management,World Journal of Gastrointestinal Oncology,2024 Mar,16(3):0 | 2024 . 03 |
8 | 鄭隆賓(Long-Bin Jeng)、王約翰(John Wang)、鄧喬方(Teng,Chiao-Fang)*,Predictive Biomarkers of Immune Checkpoint Inhibitor-Based Mono- and Combination Therapies for Hepatocellular Carcinoma,Journal of Cancer,2024 Jan,15(2):484-493 | 2024 . 01 |
9 | 林育楷(Yu-Kai Lin)、蕭連城(Lien-Cheng Hsiao)、吳美瑤(Mei-Yao Wu)、(Yun-Fang Chen)、林晏年(Yen-Nien Lin)、張家銘(Chia-Ming Chang)、鍾偉信(CHUNG WEI-HSIN)、陳科維(Ke-Wei Chen)、盧炯睿(Chiung-Ray Lu)、(Wei-Yu Chen)、徐偉成(Woei-Cheang Shyu)、張詩聖(Shih-Sheng Chang)、李安生(An-Sheng Lee)*、(Chu-Huang Chen)、鄭隆賓(Long-Bin Jeng)*、張坤正(Kuan-Cheng Chang)*,PD-L1 and AKT Overexpressing Adipose-Derived Mesenchymal Stem Cells Enhance Myocardial Protection by Upregulating CD25+ T Cells in Acute Myocardial Infarction Rat Model,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2023 Dec,(): | 2023 . 12 |
10 | 林瑄翎(LIN SYUAN-LING)、李瑋(Wei Lee)、劉詩平(Shih-Ping Liu)、張怡雯(CHANG YI-WEN)*、鄭隆賓(Long-Bin Jeng)*、徐偉成(Woei-Cheang Shyu)*,Novel Programmed Death Ligand 1‑AKT‑engineered Mesenchymal Stem Cells Promote Neuroplasticity to Target Stroke Therapy,MOLECULAR NEUROBIOLOGY,2023 Nov,s12035(023):3779-3796 | 2023 . 11 |
11 | 張哲睿(CHANG CHE-JUI)、許偉帆(Hsu, Wei-Fan)*、鄭隆賓(Long-Bin Jeng)、賴學洲(Hsueh-Chou Lai)、許士超(Shih-Chao Hsu)、陳德鴻(Te-Hung Chen)、王鴻偉(Hung-Wei Wang)、彭成元(Peng, Cheng-Yuan),Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion,Current Oncology,2023 Nov,30(12):10134-10141 | 2023 . 11 |
12 | 劉鼎元(Ting-Yuan Liu)、廖啟州(LIAO CHI-CHOU)、張雅琁(Ya-Sian Chang)、陳郁佳(Yu-Chia Chen)、陳鴻大(CHEN HONG DA)、賴羿如(I-Lu Lai)、彭成元(Peng, Cheng-Yuan)、鍾謹駿(Chin-Chun Chung)、周育葆(Yu-Pao Chou)、蔡輔仁(Fuu-Jen Tsai)*、鄭隆賓(Long-Bin Jeng)、張建國(Jan-Gowth Chang)*,Identification of 13 Novel Loci in A Genome-Wide Association Study on Taiwanese with Hepatocellular Carcinoma,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2023 Nov,24(22):16417-16417 | 2023 . 11 |
13 | 許斐婷(Hsu, Fei-Ting)、(Wei-Lin Liu)、李欣融(Sin-Rong Lee)、鄭隆賓(Long-Bin Jeng)、陳健驊(Jiann-Hwa Chen)*,Unveiling nature’s potential weapon: Magnolol’s role in combating bladder cancer by upregulating the miR-124 and inactivating PKC-δ/ERK axis,PHYTOMEDICINE,2023 Oct,119():154947 | 2023 . 10 |
14 | 鄭隆賓(Long-Bin Jeng)、李采娟(Tsai-Chung Li)、王約翰(John Wang)、鄧喬方(Chiao-Fang Teng)*,Increased Plasma Levels of Monocyte Chemoattractant Protein-1 in Patients with Hepatitis B Virus Pre-S2 Gene Deletion Mutation Predict A Higher Risk of Hepatocellular Carcinoma Recurrence after Curative Surgical Resection,CANCER,2023 Sep,129(17):2621-2636 | 2023 . 09 |
15 | 王啟鴻(Wang, Chie-Hong)、(Yi-Fang Huang)、徐偉成(Woei-Cheang Shyu)*、鄭隆賓(Long-Bin Jeng)*、劉詩平(Shih-Ping Liu)*,Cbx7 promotes the generation of induced pluripotent stem cells,Regenerative Therapy,2023 Sep,(): | 2023 . 09 |
16 | 陳怡儒(I-Ru Chen)、汪貴珍(Guei-Jane Wang)*、薛博仁(Hsueh, Po-Ren)、周家卉(Chia-Hui Chou)、鄭隆賓(Long-Bin Jeng)、林惠茹(Hui-Ju Lin)、廖凰君(Huang-Jiun Liao)、賴彬卿(Ping-Chin Lai)、張建國(Jan-Gowth Chang)、黃秋錦(Chiu-Ching Huang),Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan,Vaccine,2023 Aug,41(2023):5940-5945 | 2023 . 08 |
17 | 黃旭山(Hsu-Shan Huang)、蔣宜蒼(I-Tsang Chiang)、(Bashir Lawal)、翁悅珊(Weng, Yue-Shan)、鄭隆賓(Long-Bin Jeng)、(Yu-Cheng Kuo)、劉育昌(Yu-Chang Liu)、許斐婷(Hsu, Fei-Ting)*,A Novel Isotope-labeled Small Molecule Probe CC12 for Antiglioma via Suppressing LYN-mediated Progression and Activating Apoptosis Pathways,International Journal of Biological Sciences,2023 Jun,19(10):3209-3225 | 2023 . 06 |
18 | 賴香君(Hsiang-Chun Lai)、林宏任(Hung-jen Lin)、施盈秀(Ying-Hsiu Shih)、周仁偉(Jen-Wei Chou)、林冠妏(Kuan-Wen Lin)、鄭隆賓(Long-Bin Jeng)、黃升騰(Sheng-Teng Huang)*,LipoCol Forte capsules reduce the risk of liver cancer: A propensity score-matched, nationwide, population-based cohort study,World Journal of Gastrointestinal Oncology,2023 May,15(5):828-842 | 2023 . 05 |
19 | 林怡君(LIN YI-CHUN)、廖子琦(Tzu-Chi Liao)、林建德(Chien-Te Lin)、鄭隆賓(Long-Bin Jeng)、楊宏仁(Horng-Ren Yang)、徐中和(Chung-Ho Hsu)、林維卿(Wei-Ching Lin)、吳青(Ching-Feng Wu)*、葉俊杰(Yeh, Chun-Chieh)*,Salvage Surgeries for Splanchnic Artery Aneurysms after Failed Endovascular Therapy – Case Series,International Journal of Surgery,2023 May,10.1097(): | 2023 . 05 |
20 | 張雅琁(Ya-Sian Chang)、(Siang-Jyun Tu)、陳鴻大(CHEN HONG DA)、(Chin-Chun Chung)、(Ming-Hon Hsu)、(Yu-Pao Chou)、李雅婷(Ya-Ting Lee)、顏汝珍(Ju-Chen Yen)、鄭隆賓(Long-Bin Jeng)*、張建國(Jan-Gowth Chang)*,Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas,Biomarker Research,2023 Apr,(): | 2023 . 04 |
21 | (Yung-Chi Lai)、吳國禎(Kuo-Chen Wu)、張朝任(CHANG CHAO JEN)、陳奕瑾(Yi-Jin Chen)、王冠斌(WANG KUAN-PIN)、鄭隆賓(Long-Bin Jeng)*、高嘉鴻(Chia-Hung Kao)*,Predicting Overall Survival with Deep Learning from 18F-FDG PET-CT Images in Patients with Hepatocellular Carcinoma before Liver Transplantation,Diagnostics,2023 Mar,13(5):981 | 2023 . 03 |
22 | 鄭隆賓(Long-Bin Jeng)、李采娟(Tsai-Chung Li)、詹雯玲(Wen-Ling Chan)、鄧喬方(Chiao-Fang Teng)*,Combination of Hepatitis B Virus Pre-S2 Gene Deletion Mutation and Tumor-Node-Metastasis Stage Predicts Higher Hepatocellular Carcinoma Recurrence after Curative Surgical Resection,Biomedicines,2023 Mar,11(3):923 | 2023 . 03 |
23 | 鄭隆賓(Long-Bin Jeng)、詹雯玲(Wen-Ling Chan)、鄧喬方(Chiao-Fang Teng)*,Prognostic Significance of Serum Albumin Level and Albumin-Based Mono- and Combination Biomarkers in Patients with Hepatocellular Carcinoma,Cancers,2023 Feb,15(4):1005 | 2023 . 02 |
24 | 賴彥合(LAI YEN-HO)、(Chia-Yu Su)、(Hung-Wei Cheng)、(Chao-Yi Chu)、鄭隆賓(Long-Bin Jeng)、江智聖(CHIANG, CHIH-SHENG)*、徐偉成(Woei-Cheang Shyu)*、陳三元*,Stem cell–nanomedicine system as a theranostic bio-gadolinium agent for targeted neutron capture cancer therapy,Nature Communications,2023 Jan,14(1):285 | 2023 . 01 |
25 | 賴香君(Hsiang-Chun Lai)、林宏任(Hung-jen Lin)、鄭隆賓(Long-Bin Jeng)、黃升騰(Sheng-Teng Huang)*,Roles of conventional and complementary therapies in recurrent hepatocellular carcinoma,World Journal of Gastrointestinal Oncology,2023 Jan,15(1):19-35 | 2023 . 01 |
26 | 林維卿(Wei-Ching Lin)、陳君明(CHEN CHUN-MING)、(Antonio Carlos Westphalen)、林子揚(Lin-Tzu-Yang)、張家豪(Chia Hao Chang)、(Li-Kuang Chen)、林家緯(Chia-Wei Lin)、葉俊杰(Chun-Chieh Yeh)、游家鑫(Jiaxin Yu)、鄭隆賓(Long-Bin Jeng)、陳中和(Jeon Hor Chen)*,Non-Contrast-Enhanced MR Arteriography of Potential Living-Related Liver Donor: Using Contrast Enhanced CT Arteriography as Standard Reference,JOURNAL OF MAGNETIC RESONANCE IMAGING,2022 Dec,(): | 2022 . 12 |
27 | 張雅琁(Ya-Sian Chang)、塗翔鈞(TU SIANG-JYUN)、陳鴻大(CHEN HONG DA)、徐銘鴻(HSU MING-HUNG)、陳郁佳(Yu-Chia Chen)、趙代勝(Dy-San Chao)、鍾謹駿、(Yu-Pao Chou)、張傑閔(Chieh-Min Chang)、李雅婷(Ya-Ting Lee)、顏汝珍(Ju-Chen Yen)、鄭隆賓(Long-Bin Jeng)、張建國(Jan-Gowth Chang)*,Integrated genomic analyses of hepatocellular carcinoma,Hepatology International,2022 Oct,-(): | 2022 . 10 |
28 | 張雅琁(Ya-Sian Chang)、(Yu?Pao Chou)、鍾謹駿、李雅婷(Ya-Ting Lee)、顏汝珍(Ju-Chen Yen)、鄭隆賓(Long-Bin Jeng)*、張建國(Jan-Gowth Chang)*,Molecular Classification of Hepatocellular Carcinoma Using Wnt‐Hippo Signaling Pathway‐Related Genes,Cancers,2022 Oct,14():4580 | 2022 . 10 |
29 | 林瑄翎(LIN SYUAN-LING)、林智暘(Chih-Yang Lin)、李瑋(Wei Lee)、鄧喬方(Chiao-Fang Teng)、徐偉成(Woei-Cheang Shyu)*、鄭隆賓(Long-Bin Jeng)*,Mini Review: Molecular Interpretation of the IGF/IGF-1R Axis in Cancer Treatment and Stem Cells-Based Therapy in Regenerative Medicine,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2022 Oct,23(19):11781-11795 | 2022 . 10 |
30 | 鄭隆賓(Long-Bin Jeng)、廖力穎(Li-Ying Liao)、施富瀛(SHIH FU-YING)、鄧喬方(Chiao-Fang Teng)*,Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies,Cancers,2022 Sep,14(18):4380 | 2022 . 09 |
31 | 陳智皓(CHEN CHIH-HAO)、張坤正(Kuan-Cheng Chang)*、林晏年(Yen-Nien Lin)、何茂旺(Mao-Wang Ho)、鄭孟瑜(Meng-Yu Cheng)、施文心(HSIH WEN HSIN)、周家卉(Chia-Hui Chou)、林伯昌(Po-Chang Lin)、齊治宇(Chih-Yu Chi)、盧敏吉(Min-Chi Lu)、田霓(Ni Tien)、吳美瑤(Mei-Yao Wu)、張詩聖(Shih-Sheng Chang)、徐武輝(Wu-Huei Hsu)、徐偉成(Woei-Cheang Shyu)*、周德陽(Der-Yang Cho)、鄭隆賓(Long-Bin Jeng)*,Mesenchymal Stem Cell Therapy on Top of Triple Therapy with Remdesivir, Dexamethasone, and Tocilizumab Improves PaO2/FiO2 in Severe COVID-19 Pneumonia,Frontiers in Medicine,2022 Sep,(): | 2022 . 09 |
32 | 蕭連城(Lien-Cheng Hsiao)、林晏年(Yen-Nien Lin)、徐偉成(Woei-Cheang Shyu)、何銘(Ming- Ho)、盧炯睿(Chiung-Ray Lu)、張詩聖(Shih-Sheng Chang)、王宇澄(Yu-Chen Wang)、陳建佑(Jan-Yow Chen)、呂尚謁(Shang-yeh Lu)、吳美瑤(Mei-Yao Wu)、李庚原(Keng-Yuan Li)、林育楷(Yu-Kai Lin)、(Wen-Yih I. Tseng)、(Mao-Yuan Su)、(Chin-Ting Hsu)、(Cheng-Kang Tsai)、(Lu-Ting Chiu)、(Chien-Lin Chen)、林橙莉(Cheng-Li Lin)、胡凱傑、周德陽(Der-Yang Cho)、蔡長海(Chang-Hai Tsai)、張坤正(Kuan-Cheng Chang)*、鄭隆賓(Long-Bin Jeng)*,First-in-Human Pilot Trial of Combined Intracoronary and Intravenous Mesenchymal Stem Cell Therapy in Acute Myocardial Infarction,Frontiers in Cardiovascular Medicine,2022 Jul,(): | 2022 . 07 |
33 | 鄭隆賓(Long-Bin Jeng)、李采娟(Tsai-Chung Li)、許士超(Shih-Chao Hsu)、鄧喬方(Chiao-Fang Teng)*,Association of Increased Programmed Death Ligand 1 Expression and Regulatory T Cells Infiltration with Higher Hepatocellular Carcinoma Recurrence in Patients with Hepatitis B Virus Pre-S2 Mutant after Curative Surgical Resection,Viruses-Basel,2022 Jun,14(6):1346 | 2022 . 06 |
34 | (Jong-Ho Cha)、(Li-Chuan Chan)、(Ying-Nai Wang)、(Yu-Yi Chu)、王啟鴻(Wang, Chie-Hong)、(Heng-Huan Lee)、(Weiya Xia)、徐偉成(Woei-Cheang Shyu)、劉詩平(Shih-Ping Liu)、(Jun Yao)、(Chiung-Wen Chang)、(Fan-Ru Cheng)、(Jielin Liu)、(Seung-Oe Lim)、(Jennifer L. Hsu)、楊文豪(Yang,Wen-Hao)、(Gabriel N. Hortobagyi)、(Chunru Lin)、(Liuqing Yang)、(Dihua Yu)、鄭隆賓(Long-Bin Jeng)*、洪明奇(Mien-Chie Hung)*,Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer,JOURNAL OF BIOLOGICAL CHEMISTRY,2022 Apr,298(4):101817-101832 | 2022 . 04 |
35 | 陳曄(Chen,Yeh)、楊文豪(Yang,Wen-Hao)、陳筱凡(Chen Hsiao-Fan)、(Li-Min Huang)、(Jing-Yan Gao)、林振文(Lin, Cheng-Wen)、(Yu-Chuan Wang)、(Chia-Shin Yang)、(Yi-Liang Liu)、(Mei-Hui Hou)、(Chia-Ling Tsai)、(Yi-Zhen Chou)、(Bao-Yue Huang)、(Chian-Fang Hung)、洪育琳(Hung, Yu-Lin)、王韋然(Wang, Wei-Jan)、蘇文琪(Wen-Chi Su)、(Vathan Kumar)、(Yu-Chieh Wu)、(Shih-Wei Chao)、(Chih-Shiang Chang)、(Jin-Shing Chen)、(Yu-Ping Chiang)、周德陽(Der-Yang Cho)、鄭隆賓(Long-Bin Jeng)、蔡長海(Chang-Hai Tsai)、洪明奇(Mien-Chie Hung)*,Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2,JOURNAL OF BIOLOGICAL CHEMISTRY,2022 Mar,298(3):1-15 | 2022 . 03 |
36 | 賴彬卿(Ping-Chin Lai)、鄭旭辰(Cheng-Hsu Chen)、鄭隆賓(Long-Bin Jeng)、(Tung-Min Yu)、蔡尚峰(Shang-Feng Tsai)、吳明儒(Ming-Ju Wu)、鄭紹彬(Shao-Bin Cheng)、楊勝舜(Sheng-Shun Yang)、李騰裕(Teng-Yu Lee)*,Grazoprevir/Elbasvir Treatment in Liver or Kidney Transplant Recipients with Genotype 1b Hepatitis C Virus Infection,ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,2022 Feb,66(2): | 2022 . 02 |
37 | 林岳德(Yueh-Te Lin)、鄭隆賓(Long-Bin Jeng)、蘇益仁(Ih-Jen Su)、鄧喬方(Chiao-Fang Teng)*,Approaches for Detection of Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins and Their Application in Prediction of Higher Risk of Hepatocellular Carcinoma Development and Recurrence,Viruses-Basel,2022 Feb,14(2):428 | 2022 . 02 |
38 | 江智聖(CHIANG, CHIH-SHENG)*、黃柏傑(HUANG BO-JIE)、陳睿妤(CHEN JUI-YU)、錢韋薇(CHIENG WEE-WEI)、(Seh Hing Lim)、李瑋、徐偉成(Woei-Cheang Shyu)*、鄭隆賓(Long-Bin Jeng)*,Fucoidan-Based Nanoparticles with Inherently Therapeutic Efficacy for Cancer Treatment,Pharmaceutics,2021 Nov,13(12):1986 | 2021 . 11 |
39 | 鄭隆賓(Long-Bin Jeng)、李采娟(Tsai-Chung Li)、許士超(Shih-Chao Hsu)、詹雯玲(Wen-Ling Chan)、鄧喬方(Chiao-Fang Teng)*,Association of Low Serum Albumin Level with Higher Hepatocellular Carcinoma Recurrence in Patients with Hepatitis B Virus Pre-S2 Mutant after Curative Surgical Resection,Journal of Clinical Medicine,2021 Sep,10(18):4187 | 2021 . 09 |
40 | 鄧喬方(Chiao-Fang Teng)*、王庭(Ting Wang)、施富瀛(SHIH FU-YING)、徐偉成(Woei-Cheang Shyu)*、鄭隆賓(Long-Bin Jeng)*,Therapeutic Efficacy of Dendritic Cell Vaccine Combined with Programmed Death 1 Inhibitor for Hepatocellular Carcinoma,JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,2021 Jul,36(7):1988-1996 | 2021 . 07 |
41 | 洪皓脩(Hao-Hsiu Hung)、黃超俊(Chao-Chun Huang)、林美辰(Mei-Chen Lin)、黃升騰(Sheng-Teng Huang)*、鄭隆賓(Long-Bin Jeng)*,Evaluation of delayed bleeding risks associated with partial hepatectomy: A nationwide population-based propensity score matching study,International Journal of Surgery,2021 Jun,1(90):105980 | 2021 . 06 |
42 | 林岳德(Yueh-Te Lin)、鄭隆賓(Long-Bin Jeng)、詹雯玲(Wen-Ling Chan)、蘇益仁(Ih-Jen Su)、鄧喬方(Chiao-Fang Teng)*,Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins: Clinical and Molecular Implications in Hepatocellular Carcinoma,Viruses-Basel,2021 May,13(5):862 | 2021 . 05 |
43 | 鄧喬方(Chiao-Fang Teng)*、李采娟(Tsai-Chung Li)、王庭(Ting Wang)、廖大慶(Liao Da Ching)、文翊軒(Yi-Hsuan Wen)、吳慈華(Tzu-Hua Wu)、王約翰(John Wang)、吳漢傑(Han-Chieh Wu)、徐偉成(Woei-Cheang Shyu)、蘇益仁(Ih-Jen Su)、鄭隆賓(Long-Bin Jeng)*,Increased Infiltration of Regulatory T Cells in Hepatocellular Carcinoma of Patients with Hepatitis B Virus Pre-S2 Mutant,Scientific Reports,2021 Jan,11(1):1136 | 2021 . 01 |
44 | 鄧喬方(Chiao-Fang Teng)*、李采娟(Tsai-Chung Li)、王庭(Ting Wang)、吳慈華(Tzu-Hua Wu)、王約翰(John Wang)、吳漢傑(Han-Chieh Wu)、徐偉成(Woei-Cheang Shyu)、蘇益仁(Ih-Jen Su)、鄭隆賓(Long-Bin Jeng)*,Increased Expression of Programmed Death Ligand 1 in Hepatocellular Carcinoma of Patients with Hepatitis B Virus Pre-S2 Mutant,Journal of Hepatocellular Carcinoma,2020 Dec,7():385-401 | 2020 . 12 |
45 | 鄧喬方(Chiao-Fang Teng)*、李采娟(Tsai-Chung Li)、黃熙淵(Hsi-Yuan Huang)、詹雯玲(Wen-Ling Chan)、吳漢傑(Han-Chieh Wu)、徐偉成(Woei-Cheang Shyu)、蘇益仁(Ih-Jen Su)*、鄭隆賓(Long-Bin Jeng)*,Hepatitis B virus pre-S2 deletion (nucleotide 1 to 54) in plasma predicts recurrence of hepatocellular carcinoma after curative surgical resection,PLoS One,2020 Nov,15(11):e0242748 | 2020 . 11 |
46 | 葉俊杰(Chun-Chieh Yeh)、廖珮吟、(Sudhir Pandey)、楊姝紜、賴學洲(Hsueh-Chou Lai)、鄭隆賓(Long-Bin Jeng)、張維君(Wei-Chun Chang)、馬文隆(Wen-Lung Ma)*,Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-clinical Models,Frontiers in Oncology,2020 Oct,11(): | 2020 . 10 |
47 | 許士超(Shih-Chao Hsu)、(Ashok Thorat)、鄭隆賓(Long-Bin Jeng)*、李秉純(Ping-Chun Li)、陳德鴻(Te-Hung Chen)、楊宏仁(Horng-Ren Yang)、潘健成(Kin-Shing Poon),ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients - Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?,Annals of Transplantation,2020 Sep,25():1-11 | 2020 . 09 |
48 | 陳曄(Chen,Yeh)、楊文豪(Yang,Wen-Hao)、(Li-Min Huang)、王昱權(WANG YU-CHUAN)、楊佳昕(Yang, Chia-Shin)、(Yi-Liang Liu)、侯美慧、蔡佳綾(Tsai, Chia-Ling)、周易蓁(CHOU,YI-ZHEN)、黃寶月、洪千雱、洪育琳(Hung, Yu-Lin)、(Jin-Shing Chen)、(Yu-Ping Chiang)、周德陽(Der-Yang Cho)、鄭隆賓(Long-Bin Jeng)、蔡長海(Chang-Hai Tsai)、洪明奇(Mien-Chie Hung)*,Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 main protease by tafenoquine in vitro,bioRxiv,2020 Aug,(): | 2020 . 08 |
49 | 鄧喬方(Chiao-Fang Teng)*、吳漢傑(Han-Chieh Wu)、蘇益仁(Ih-Jen Su)*、鄭隆賓(Long-Bin Jeng)*,Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for The Development and Recurrence of Hepatocellular Carcinoma,Viruses-Basel,2020 Aug,12(9):945 | 2020 . 08 |
50 | 鄧喬方(Chiao-Fang Teng)*、李采娟(Tsai-Chung Li)、黃熙淵(Hsi-Yuan Huang)、林佳慧(Jia-Hui Lin)、陳雯淑(Wen-Shu Chen)、徐偉成(Woei-Cheang Shyu)、吳漢傑(Han-Chieh Wu)、彭成元(Cheng-Yuan Peng)、蘇益仁(Ih-Jen Su)*、鄭隆賓(Long-Bin Jeng)*,Next-Generation Sequencing-Based Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma Predicts Hepatocellular Carcinoma Recurrence,Viruses-Basel,2020 Jul,12(8):796 | 2020 . 07 |
51 | 鄧喬方(Chiao-Fang Teng)*、王庭(WANG TING)、吳慈華(Tzu-Hua Wu)、林佳慧(Jia-Hui Lin)、施富瀛(SHIH FU-YING)、徐偉成(Woei-Cheang Shyu)*、鄭隆賓(Long-Bin Jeng)*,Combination Therapy with Dendritic Cell Vaccine and Programmed Death Ligand 1 Immune Checkpoint Inhibitor for Hepatocellular Carcinoma in An Orthotopic Mouse Model,Therapeutic Advances in Medical Oncology,2020 Jun,12():1758835920 | 2020 . 06 |
52 | 鄧喬方(Chiao-Fang Teng)*、蔡弘文(Hung-Wen Tsai)、李采娟(Tsai-Chung Li)、王庭(Ting Wang)、王約翰(John Wang)、徐偉成(Woei-Cheang Shyu)、吳漢傑(Han-Chieh Wu)、蘇益仁(Ih-Jen Su)*、鄭隆賓(Long-Bin Jeng)*,Detection of Hepatitis B Virus Pre-S Mutants in Plasma by A Next-Generation Sequencing-Based Platform Determines Their Patterns in Liver Tissues,PLoS One,2020 Jun,15(6):e0234773 | 2020 . 06 |
53 | 葉俊杰(Chun-Chieh Yeh)、(Arshad Khan)*、(Chih-Hsin Muo)、楊宏仁(Horng-Ren Yang)、李秉純(Ping-Chun Li)、張兆祥(Chao-Hsiang Chang)、(Ta-Liang Chen)、鄭隆賓(Long-Bin Jeng)、廖建彰(LIAO, CHIEN-CHANG)*,De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan,Experimental and Clinical Transplantation,2020 Apr,18(2):224-233 | 2020 . 04 |
54 | 林詩怡(Shih-Yi Lin)、林橙莉(Cheng-Li Lin)、徐武輝(Wu-Huei Hsu)、王怡寬(I-Kuan Wang)、林正介(Cheng-Chieh Lin)、鄭隆賓(Long-Bin Jeng)、高嘉鴻(Chia-Hung Kao)*,Risk of Biliary Tract Disease in Living Liver Donors: A Population-Based Cohort Study,PLoS One,2020 Mar,15(3):e0230840 | 2020 . 03 |
55 | 賴學洲(Hsueh-Chou Lai)、鍾瑋敏(Wei-Min Chung)、(Chun-Mien Chang)、(Pei-Yin Liao)、(Yu-Ting Su)、葉俊杰(Chun-Chieh Yeh)、鄭隆賓(Long-Bin Jeng)、馬文隆(Wen-Lung Ma)*、張維君(Wei-Chun Chang)*,Androgen Receptor Enhances the Efficacy of Sorafenib Against Hepatocellular Carcinoma Through Enriched EpCAM Stemness,ANTICANCER RESEARCH,2020 Mar,40(3):1285-1295 | 2020 . 03 |
56 | 陳德鴻(Te-Hung Chen)、楊宏仁(Horng-Ren Yang)、鄭隆賓(Long-Bin Jeng)*、許士超(Shih-Chao Hsu)、許家豪(Chia-Hao Hsu)、葉俊杰(Chun-Chieh Yeh)、楊美都(Mei-Due Yang)、陳自諒(Tzu-Liang Chen),Laparoscopic Liver Resection: Experience of 436 Cases in One Center,JOURNAL OF GASTROINTESTINAL SURGERY,2019 Oct,23(10):1949-1956 | 2019 . 10 |
57 | 鄧喬方(Chiao-Fang Teng)、于君彗(Chun-Hui Yu)、張鴻議(Hong-Yi Chang)、謝汶娟(Wen-Chuan Hsieh)、吳慈華(Tzu-Hua Wu)、林佳慧(Jia-Hui Lin)、吳漢傑(Han-Chieh Wu)、鄭隆賓(Long-Bin Jeng)、蘇益仁(Ih-Jen Su)*,Chemopreventive Effect of Phytosomal Curcumin on Hepatitis B Virus-Related Hepatocellular Carcinoma in A Transgenic Mouse Model,Scientific Reports,2019 Jul,9(1):10338 | 2019 . 07 |
58 | 鄧喬方(Chiao-Fang Teng)*、黃熙淵(Hsi-Yuan Huang)、李采娟(Tsai-Chung Li)、徐偉成(Woei-Cheang Shyu)、吳漢傑(Han-Chieh Wu)、林建佑(Chien-Yu Lin)、蘇益仁(Ih-Jen Su)*、鄭隆賓(Long-Bin Jeng)*,A Next-Generation Sequencing-Based Platform for Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma of Hepatocellular Carcinoma Patients,Scientific Reports,2018 Oct,8(1):14816 | 2018 . 10 |
59 | 鄧喬方(Teng, Chiao-Fang)、鄭隆賓(Jeng, Long-Bin)*、徐偉成(Shyu, Woei-Cherng)*,Role of Insulin-like Growth Factor 1 Receptor Signaling in Stem Cell Stemness and Therapeutic Efficacy,CELL TRANSPLANTATION,2018 Sep,27(9):1313-1319 | 2018 . 09 |
60 | 張維君(Chang, Wei-Chun)、鄭維中(Cheng, Wei-Chung)、(Bi-Hua Cheng)、陳璐敏(Lu-Min Chen)、(Li-Jing Ju)、(Yu-Jer Ou)、鄭隆賓(Jeng, Long-Bin)、楊美都(Yang, Mei-Due)、洪耀欽(Hung, Yao-Ching)*、馬文隆(Ma, Wen-Lung)*,Mitochondrial Acetyl-CoA Synthetase 3 is Biosignature of Gastric Cancer Progression,Cancer Medicine,2018 Aug,7(8):3743-3754 | 2018 . 08 |
61 | 鄭隆賓(Jeng, Long-Bin)*、(Sung Gyu Lee)、(Arvinder Singh Soin)、(Wei-Chen Lee)、(Kyung-Suk Suh)、(Dong Jin Joo)、(Shinji Uemoto)、(Jaewon Joh)、(Tomoharu Yoshizumi)、楊宏仁(Yang, Horng-Ren)、(Gi-Won Song)、(Patricia Lopez)、(Jossy Kochuparampil)、(Carole Sips)、(Shuhei Kaneko)、(Gary Levy),Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study,AMERICAN JOURNAL OF TRANSPLANTATION,2018 Jun,18(6):1435-1446 | 2018 . 06 |
62 | (KUEI-MAN LIN)、楊美都(Yang, Mei-Due)、蔡佳紋(Tsai, Chia-Wen)、張文馨(Chang, Wen-Shin)、(CHIEH-LUN HSIAO)、鄭隆賓(Jeng, Long-Bin)、(TE-CHENG YUEH)*、(MENG-CHIH LEE)*、包大靝(Bau, Da-Tian)*,The Role of MTHFR Genotype in Colorectal Cancer Susceptibility in Taiwan,ANTICANCER RESEARCH,2018 Apr,38(4):2001-2006 | 2018 . 04 |
63 | (Ta-Lun Kao)、(Yu-Ping Kuan)、鄭維中(Cheng, Wei-Chung)、張維君(Chang, Wei-Chun)、鄭隆賓(Jeng, Long-Bin)、(Shuyuan Yeh)*、馬文隆(Ma, Wen-Lung)*,Estrogen receptors orchestrate cell growth and differentiation to facilitate liver regeneration,Theranostics,2018 Apr,8(10):2672-2682 | 2018 . 04 |
64 | 楊宏仁(Yang, Horng-Ren)、(Ashok Thorat)、鄭隆賓(Jeng, Long-Bin)*、許士超(Shih-Chao Hsu)、李秉純(Li, Ping-Chun)、葉俊杰(Yeh, Chun-Chieh)、陳德鴻(Te-Hong Chen)、潘健成(Poon, Kin-Shing),Living Donor Liver Transplantation in Acute Liver Failure Patients with Grade IV Encephalopathy: Is Deep Hepatic Coma Still an Absolute Contraindication? A Successful Single-Center Experience,Annals of Transplantation,2018 Mar,23():176-181 | 2018 . 03 |
65 | (Chien-Hua Chen)、林橙莉、鄭隆賓(Jeng, Long-Bin)*,Association between chronic pancreatitis and urolithiasis: A population-based cohort study.,PLoS One,2018 Mar,13(3):e0194019 | 2018 . 03 |
66 | 鄭隆賓(Jeng, Long-Bin)、(Bharath Kumar Velmurugan)、(Ming-Cheng Chen)、(Hsi-Hsien Hsu)、何宗融(Ho, Tsung-Jung)、(Cecilia-Hsuan Day)、(Yueh-Min Lin)、(V. Vijaya Padma)、(Chuan-Chou Tu)*、黃志揚(Huang, Chih-Yang)*,Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo,JOURNAL OF CELLULAR PHYSIOLOGY,2018 Mar,():1-9 | 2018 . 03 |
67 | 鄭隆賓(Jeng, Long-Bin)、(Bharath Kumar Velmurugan)、(Hsi-Hsien Hsu)、(Su-Ying Wen)、(Chia-Yao Shen)、(Chih-Hao Lin)、(Yueh-Min Lin)、(Ray-Jade Chen)、郭薇雯(Kuo, Wei-Wen)*、黃志揚(Huang, Chih-Yang)*,Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells,ENVIRONMENTAL TOXICOLOGY,2018 Feb,33(2):234-247 | 2018 . 02 |
68 | 高大倫、(Chen, Yao-Li)、管育平(Kuan, Yu-Ping)、張維君(Chang, Wei-Chun)、(Ho, Yu-Chen)、(Yeh, Shuyuan)、鄭隆賓(Jeng, Long-Bin)*、馬文隆(Ma, Wen-Lung)*,Estrogen-Estrogen Receptor alpha Signaling Facilitates Bilirubin Metabolism in Regenerating Liver Through Regulating Cytochrome P450 2A6 Expression,CELL TRANSPLANTATION,2017 Nov,26(11):1822-1829 | 2017 . 11 |
69 | 吳錫金(Wu,Hsi-Chin)、賴英秀(Lay Ing Shiow)、徐布、何宗融(Tsung-Jung Ho)、(Shiu-Min Cheng)、(Chih-Hao Lin)、(Tran Duc Dung)、鄭隆賓(Long-Bin Jeng)、(Vijaya Padma Viswanadha)、黃志揚(Chih-Yang Huang)*,Zanthoxylum avicennae extract enhances GSK-3b to attenuate b-catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice,ENVIRONMENTAL TOXICOLOGY,2017 Sep,32(9):2133-2143 | 2017 . 09 |
70 | 許士超(Shih-Chao Hsu)、(Ashok Thorat)、楊宏仁(Yang, Horng-Ren)、潘健成(Poon, Kin-Shing)、李秉純(Li, Ping-Chun)、葉俊杰(Yeh, Chun-Chieh)、陳德鴻(Te-Hong Chen)、鄭隆賓(Jeng, Long-Bin)*,Assessing the Safety of Expanded Polytetrafluoroethylene Synthetic Grafts in Living Donor Liver Transplantation: Graft Migration Into Hollow Viscous Organs - Diagnosis and Treatment Options,MEDICAL SCIENCE MONITOR,2017 Jul,23():3284-3292 | 2017 . 07 |
71 | 楊美都(Mei-Due Yang)、林國誠(Kuo-Cheng Lin)、呂孟純(Meng-Chun Lu)、鄭隆賓(Long-Bin Jeng)、(Chieh-Lun Hsiao)、(Te-Cheng Yueh)、(Chun-Kai Fu)、(Hsin-Ting Li)、(Shiou-Ting Yen)、(Chia-Wen Lin)、(Cin-Wun Wu)、(Su-Yi Pang)、包大靝(Da-Tian Bau)、蔡輔仁(Fuu-Jen Tsai)*,Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan,BioMedicine,2017 Jun,7(2):18-24 | 2017 . 06 |
72 | (Chien-Hua Chen)、林橙莉、鄭書(Yu-Shu Cheng)、鄭隆賓(Long-Bin Jeng)*,Association Between Subtotal Gastrectomy with Billroth II Anastomosis and Coronary Heart Disease.,OBESITY SURGERY,2017 Jun,27(6):1604-1611 | 2017 . 06 |
73 | 李秉純(Li, Ping-Chun)、(Ashok Thorat)、許士超(Shih-Chao Hsu)、潘健成(Poon, Kin-Shing)、楊宏仁(Yang, Horng-Ren)、陳德鴻(Te-Hong Chen)、葉俊杰(Yeh, Chun-Chieh)、鄭隆賓(Jeng, Long-Bin)*,Extracorporeal Membrane Oxygenation Support for Rituximab-Induced Acute Respiratory Distress Syndrome in an ABO-Incompatible Living Donor Liver Transplant Recipient: Successful Management of a Rare Complication and a Review of the Literature,Annals of Transplantation,2017 Jun,22():463-467 | 2017 . 06 |
74 | (Chun-Yi Lin)、廖炯為(Chiung-Wei Liao)、(Lu-Yen Chu)、顏國揚(Kuo-Yang Yen)、鄭隆賓(Long-Bin Jeng)、許正男(Cheng-Nan Hsu)*、林橙莉、高嘉鴻(Chia-Hung Kao)*,Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients with Hepatocellular Carcinoma Before Liver Transplantation,CLINICAL NUCLEAR MEDICINE,2017 Apr,42(4):e183-e187 | 2017 . 04 |
75 | 李秉純(Ping-Chun Li)、(Ashok Thorat)、鄭隆賓(Long-Bin Jeng)*、楊宏仁(Horng-Ren Yang)、李明禮(Ming-Li Li)、葉俊杰(Chun-Chieh Yeh)、陳德鴻(Te-Hong Chen)、許士超(Shih-Chao Hsu)、潘健成(Kin-Shing Poon),Hepatic artery reconstruction in living donor liver transplantation using surgical loupes: Achieving low rate of hepatic arterial thrombosis in consecutive 741 recipients- Tips and tricks to overcome the poor hepatic arterial flow,LIVER TRANSPLANTATION,2017 Apr,0(): | 2017 . 04 |
76 | (YI-LIANG LAI)、龔志力(Chi-Li Gong)、(CHUN-KAI FU)、(TE-CHENG YUEH)、蔡佳紋(Tsai, Chia-Wen)、(WEN-SHIN CHANG)、(CHIEH-LUN HSIAO)、(SHIOU-TING YEN)、(HSIN-TING LI)、鄭隆賓(Long-Bin Jeng)、(SHOU-CHENG WANG)*、包大靝(Da-Tian Bau)*,The Contribution of Matrix Metalloproteinase-1 Genotypes to Hepatocellular Carcinoma Susceptibility in Taiwan,Cancer Genomics & Proteomics,2017 Mar,14(2):119-126 | 2017 . 03 |
77 | 鄧喬方(Chiao-Fang Teng)、吳漢傑(Han-Chieh Wu)、徐偉成(Woei-Cherng Shyu)、鄭隆賓(Long-Bin Jeng)*、蘇益仁(Ih-Jen Su)*,Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma,CELL TRANSPLANTATION,2017 Mar,26(3):429-438 | 2017 . 03 |
78 | 李秉純(Ping-Chun Li)、Ashok Thorat(Ashok Thorat)、鄭隆賓(Long-Bin Jeng)*、楊宏仁(Horng-Ren Yang)、李明禮(Ming-Li Li)、葉俊杰(Chun-Chieh Yeh)、陳德鴻(Te-Hong Chen)、許士超(Shih-Chao Hsu)、潘健成(Kin-Shing Poon),Successful Application Of Supra-Coeliac Aorto-Hepatic Conduit Using Saphenous Venous Graft In Right Lobe Living Donor Liver Transplantation,LIVER TRANSPLANTATION,2017 Jan,0(0):2-9 | 2017 . 01 |
79 | 許士超(Shih-Chao Hsu)、Ashok Thorat(Ashok Thorat)、潘健成(Kin-Shing Poon)、葉俊杰(Chun-Chieh Yeh)、陳德鴻(Te-Hong Chen)、楊宏仁(Horng-Ren Yang)、鄭隆賓(Long-Bin Jeng)*,Management of Liver Allograft Trauma Resulting in Massive Subcapsular Hematoma After Living Donor Liver Transplantation: Can We Salvage the Liver Allograft?,Annals of Transplantation,2017 Jan,22():1-8 | 2017 . 01 |
80 | (Chih-Wei Tseng)、林橙莉、(Yu-Tso Chen)、鄭隆賓(Long-Bin Jeng)*,Ischemic Bowel Syndrome in Patients with Spinal Cord Injury: A Nationwide Study,PLoS One,2017 Jan,12(1):e0169070 | 2017 . 01 |
81 | 張維君(Wei-Chun Chang)、(Shang-Fen Huang)、(Yang-Ming Lee)、賴學洲(Hsueh-Chou Lai)、(Bi-Hua Cheng)、鄭維中(Wei-Chung Cheng)、何彥秉、鄭隆賓(Long-Bin Jeng)、馬文隆(Wen-Lung Ma)*,Cholesterol import and steroidogenesis are biosignatures for gastric cancer patient survival,Oncotarget,2017 Jan,8(1):692-704 | 2017 . 01 |
82 | (Shih-Ting Huang)、(Ya-Wen Chuang)、(Tung-Min Yu)、林橙莉、鄭隆賓(Jeng, Long-Bin)*,Hepatointestinal complications in polycystic kidney disease,Oncotarget,2017 ,(): | 2017 . |
83 | (Ashok Thorat)、鄭隆賓(Jeng, Long-Bin)*,Management of renal dysfunction in patients with liver cirrhosis: role of pretransplantation hemodialysis and outcomes after liver transplantation,Seminars in Vascular Surgery,2016 Dec,29(4):227-235 | 2016 . 12 |
84 | Ashok Thorat(Ashok Thorat)、許士超(Shih-Chao Hsu)、楊宏仁(Horng-Ren Yang)、李秉純(Ping-Chun Li)、李明禮(Ming-Li Li)、葉俊杰(Chun-Chieh Yeh)、陳德鴻(Te-Hong Chen)、潘健成(Kin-Shing Poon)、鄭隆賓(Long-Bin Jeng)*,Reconstruction of Isolated Inferior Right Hepatic Vein(s) in Right Lobe Living Donor Liver Transplantation Using Polytetrafluoroethylene Grafts: A New Feasible Concept, Technique of ‘Bridging Conduit Venoplasty’ and Outcomes,Annals of Transplantation,2016 Dec,21():735-744 | 2016 . 12 |
85 | 楊宏仁(Horng-Ren Yang)、(Ashok Thorat)、潘健成(Kin-Shing Poon)*、(Chun-Chieh Yeh)、江易穎(Yi-Ying Chiang)、(Te-Hung Chen)、(Shih-Chao Hsu)、鄭隆賓(Long-Bin Jeng),Living Donor Hepatectomy in Female Donors with Ongoing Menstruation: Safety and Ethical issues,Formosan Journal of Surgery,2016 Dec,50(): | 2016 . 12 |
86 | 邱昌芳(Chang-Fang Chiu)、楊宏仁(Horng-Ren Yang)、楊美都(Mei-Due Yang)、鄭隆賓(Long-Bin Jeng)、楊哲彥(Tse-Yen Yang)、(Aaron M. Sargeant)、白禮源(Li-Yuan Bai)*,Palliative gastrectomy prolongs survival of metastatic gastric cancer patients with normal preoperative CEA or CA19-9 values: a retrospective cohort study,Gastroenterology Research and Practice,2016 Nov,2016():6846027 | 2016 . 11 |
87 | (Chien-Hua Chen)、(Che-Ming Hsu)、林橙莉、周安國(An-Kuo Chou)*、鄭隆賓(Long-Bin Jeng)*,The Development of Diabetes after Subtotal Gastrectomy with Billroth II Anastomosis for Peptic Ulcer Disease,PLoS One,2016 Nov,11(11):e0167321 | 2016 . 11 |
88 | 林詩怡(Shih-Yi Lin)、林橙莉、劉耀隆(Yao-Lung Liu)、徐武輝(Wu-Huei Hsu)、林正介(Cheng-Chieh Lin)、王怡寬(I-Kuan Wang)、鄭隆賓(Long-Bin Jeng)*、高嘉鴻(Chia-Hung Kao)*,Peptic ulcer disease in living liver donors: A longitudinal population-based study.,AMERICAN JOURNAL OF TRANSPLANTATION,2016 Oct,16(10):2925-2931 | 2016 . 10 |
89 | 陳建勳(Jian-Xun Chen)、鄭隆賓(Jeng, Long-Bin)、林昱森(Yu-Sen Lin)、呂庭聿(Ting-Yu Lu)、方信元(Fang, Hsin-Yuan)*,A Mimicking Esophageal Cancer After Liver Transplant for Hepatocellular Carcinoma: A Rare Posttransplant Metastasis.,Experimental and Clinical Transplantation,2016 Oct,14(5):571-574 | 2016 . 10 |
90 | (Ming-Shian Tsai)、林橙莉、鄭隆賓(Long-Bin Jeng)*,Gastrectomy is Associated with an Increased Risk of Pyogenic Liver Abscess: A 13-Year Nationwide Cohort Study,Scientific Reports,2016 Sep,6():33788 | 2016 . 09 |
91 | 葉俊杰(Chun-Chieh Yeh)、廖建彰(Chien-Chang Liao)、施純全(Chun-Chuan Shih)、鄭隆賓(Long-Bin Jeng)、陳大樑(Ta-Liang Chen)*,Postoperative adverse outcomes among physicians receiving major surgeries: a nationwide retrospective cohort study,MEDICINE,2016 Sep,95(39):e4946-e4946 | 2016 . 09 |
92 | 賴學洲(Hsueh-Chou Lai)、葉俊杰(Chun-Chieh Yeh)、鄭隆賓(Long-Bin Jeng)、黃上峰(Shang-Fen Huang)、廖珮吟(Liao, Pei-Yin)、雷馥如(Lei, Fu Ju)、鄭維中(Wei-Chung Cheng)、徐正龍(Cheng-Lung Hsu)、蔡秀軍(Xiujun Cai)、張傳祥(Chawnshang Chang)、馬文隆(Wen-Lung Ma)*,Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells,Oncotarget,2016 Jul,(): | 2016 . 07 |
93 | 邱昌芳(Chang-Fang Chiu)、楊宏仁(Horng-Ren Yang)、楊美都(Mei-Due Yang)、鄭隆賓(Long-Bin Jeng)、(Aaron M. Sargeant)、葉士芃(Su-Peng Yeh)、白禮源(Li-Yuan Bai)*,The role of adjuvant chemotherapy for patients with stage II and stage III gastric adenocarcinoma after surgery plus D2 lymph node dissection: a real-world observation,SpringerPlus,2016 Jun,20165():728 | 2016 . 06 |
94 | THORAT ASHOK(THORAT ASHOK)、鄭隆賓(Long-Bin Jeng)*、楊宏仁(Horng-Ren Yang)、李秉純(Ping-Chun Li)、李明禮(Ming-Li Li)、葉俊杰(Chun-Chieh Yeh)、陳德鴻(Te-Hong Chen)、許士超(Shih-Chao Hsu)、潘健成(Kin-Shing Poon),Outflow Reconstruction for Right Liver Allograft with Multiple Hepatic Veins: “V-Plasty” of Hepatic Veins to Form a Common Outflow Channel Versus 2 or More Hepatic Vein–to–Inferior Vena Cava Anastomoses in Limited Retrohepatic Space,LIVER TRANSPLANTATION,2016 Feb,22(2):192-200 | 2016 . 02 |
95 | (Li-Min Sun)、(Ming-Chia Lin)、林橙莉、梁基安(Ji-An Liang)、鄭隆賓(Long-Bin Jeng)、高嘉鴻(Chia-Hung Kao)*、(Chiao-Yi Lu)*,Nonalcoholic Cirrhosis Increased Risk of Digestive Tract Malignancies: A Population-Based Cohort Study,MEDICINE,2015 Dec,94(49):e2080 | 2015 . 12 |
96 | 鄭隆賓(Long-Bin Jeng)*、THORAT ASHOK(THORAT ASHOK)*、李秉純(Ping-Chun Li)、李明禮(Ming-Li Li)、楊宏仁(Horng-Ren Yang)、葉俊杰(Chun-Chieh Yeh)、陳德鴻(Te-Hong Chen)、許家豪(Chia-Hao Hsu)、許士超(Shih-Chao Hsu)、潘健成(Kin-Shing Poon),V-Plasty technique using dual synthetic vascular grafts to reconstruct outflow channel in living donor liver transplantation,SURGERY,2015 Nov,158(5):1272-1282 | 2015 . 11 |
97 | (Yin Lin)、鄭隆賓(Long-Bin Jeng)、(Hsin-Yi Wang)、(Shih-Chuan Tsai)、(Wan-Yu Lin)、高嘉鴻(Chia-Hung Kao)*,Clinical Value of 18F-FDG PET/CT in Detecting Adrenal Metastasis in Patients with Hepatocellular Carcinoma.,TECHNOLOGY IN CANCER RESEARCH & TREATMENT,2015 Oct,14(5):593-599 | 2015 . 10 |
98 | 楊美都(Mei-Due Yang)、許欽木(Chin-Mu Hsu)、張文馨(Wen-Shin Chang)、(Te-Cheng Yueh)、(Yu-Liang Lai)、(Chin-Liang Chuang)、(Shou-Cheng Wang)、鄭隆賓(Long-Bin Jeng)、(Hong-Xue Ji)、(Chieh-Lun Hsiao)、(Cheng-Nan Wu)、(Chia-Wen Tsai)、鍾景光(Jing-Gung Chung)、包大靝(Da-Tian Bau)*,Tumor Necrosis Factor-α Genotypes Are Associated with Hepatocellular Carcinoma Risk in Taiwanese Males, Smokers and Alcohol Drinkers,ANTICANCER RESEARCH,2015 Oct,35(10):5417-5423 | 2015 . 10 |
99 | (Ming-Shian Tsai)、王昱喬(Wang Yu Chiao)、(Yin-Hsien Kao)、鄭隆賓(Long-Bin Jeng)、高嘉鴻(Chia-Hung Kao)*,Preexisting Diabetes and Risks of Morbidity and Mortality After Gastrectomy for Gastric Cancer: A Nationwide Database Study.,MEDICINE,2015 Sep,94(37):e1467 | 2015 . 09 |
100 | (Li-Min Sun)、陳宣如、鄭隆賓(Long-Bin Jeng)、李采娟(Tsai-Chung Li)、吳汐淇(Shih-Chi Wu)、高嘉鴻(Chia-Hung Kao)*,Splenectomy and increased subsequent cancer risk: a nationwide population-based cohort study.,AMERICAN JOURNAL OF SURGERY,2015 Aug,210(2):243-251 | 2015 . 08 |
101 | (Ming-Shian Tsai)、王昱喬、(Hsi-Hao Wang)、(Po-Huang Lee)、鄭隆賓(Long-Bin Jeng)、高嘉鴻(Chia-Hung Kao)*,Pre-existing diabetes and risks of morbidity and mortality after liver transplantation: A nationwide database study in an Asian population.,European Journal of Internal Medicine,2015 Jul,26(6):433-438 | 2015 . 07 |
102 | 謝逸憲(Yi-Hsien Hsieh)、張文馨(Wen-Shin Chang)、蔡佳紋(Chia-Wen Tsai)、(Jen-Pi Tsai)、許欽木(Chin-Mu Hsu)、鄭隆賓(Long-Bin Jeng)、包大靝(Da-Tian Bau)*,DNA double-strand break repair gene XRCC7 genotypes were associated with hepatocellular carcinoma risk in Taiwanese males and alcohol drinkers,TUMOR BIOLOGY,2015 Jun,36(6):4101-4106 | 2015 . 06 |
103 | (Li-Min Sun)、郭煌宗(Haung-Tsung Kuo)、鄭隆賓(Long-Bin Jeng)、林橙莉、梁基安(Ji-An Liang)、高嘉鴻(Chia-Hung Kao)*,Hypertension and Subsequent Genitourinary and Gynecologic Cancers Risk: A Population-Based Cohort Study,MEDICINE,2015 Apr,94(16):e753 | 2015 . 04 |
104 | (Ming-Shian Tsai)、(Sheng-En Chou)、(Hong-Shiee Lai)、鄭隆賓(Long-Bin Jeng)、林橙莉、高嘉鴻(Chia-Hung Kao)*,Long-Term Risk of Acute Coronary Syndrome in Splenectomized Patients Due to Splenic Injury.,MEDICINE,2015 Mar,94(9):610 | 2015 . 03 |
105 | 潘健成(Kin-Shing Poon)、陳家臻(Chia-Chen Chen)、THORAT ASHOK(THORAT ASHOK)、江易穎(Yi-Ying Chiang)、鄭隆賓(Long-Bin Jeng)*、楊宏仁(Horng-Ren Yang)、陳德鴻(Te-Hong Chen)、葉俊杰(Chun-Chieh Yeh)、陳坤堡(Kuen-Bao Chen),Fibrinolysis after reperfusion of liver graft,Acta Anaesthesiologica Taiwanica,2015 Mar,53(1):41-43 | 2015 . 03 |
106 | 葉俊杰(Chun-Chieh Yeh)、(Jaw-Town Lin)、鄭隆賓(Long-Bin Jeng)、(Hsiu J. Ho)、楊宏仁(Horng-Ren Yang)、(Ming-Shiang Wu)、(Ken N. Kuo)、吳俊穎(Chun-Ying Wu)*,Nonsteroidal Anti-inflammatory Drugs Are Associated With Reduced Risk of Early Hepatocellular Carcinoma Recurrence After Curative Liver Resection,ANNALS OF SURGERY,2015 Mar,261(3):521-526 | 2015 . 03 |
107 | 鄭隆賓(Long-Bin Jeng)*、THORAT ASHOK(THORAT ASHOK)*、楊宏仁(Horng-Ren Yang)、葉俊杰(Chun-Chieh Yeh)、陳德鴻(Te-Hong Chen)、許家豪(Chia-Hao Hsu)、許士超(Shih-Chao Hsu)、潘健成(Kin-Shing Poon)、李秉純(Ping-Chun Li)、賴學洲(Hsueh-Chou Lai)、蘇文邦(Wen-Pang Su)、彭成元(Cheng-Yuan Peng),Successful use of hepatitis B surface antigen-positive liver grafts - an effective source for donor organs in endemic areas: a single-center experience,Annals of Transplantation,2015 Feb,20():103-111 | 2015 . 02 |
108 | 葉俊杰(Chun-Chieh Yeh)、詹佳穎(Chia-Ing Jan)、楊宏仁(Horng-Ren Yang)、(Po-Han Huang)、鄭隆賓(Long-Bin Jeng)、蘇文邦(Wen-Pang Su)、陳惠珍(Hui-Chen Chen)*,Comparison and Efficacy of LigaSure and Rubber Band Ligature in Closing the Inflamed Cecal Stump in a Rat Model of Acute Appendicitis,Biomed Research International,2014 Oct,2015(2015):260312-260319 | 2014 . 10 |
109 | (Chun-Jen Liu)、(Juliana Chang)、(Po-Huang Lee)、(Deng-Yn Lin)、(Cheng-Chung Wu)、鄭隆賓(Long-Bin Jeng)、(Yih-Jyh Lin)、(King-Tong Mok)、(Wei-Chen Lee)、(Hong-Zen Yeh)、(Ming-Chih Ho)、(Sheng-Shun Yang)、楊美都(Mei-Due Yang)、(Ming-Chin Yu)、(Rey-Heng Hu)、彭成元(Cheng-Yuan Peng)、(Kuan-Lang Lai)、(Stanley Shi-Chung Chang)、(Pei-Jer Chen)*,Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence,WORLD JOURNAL OF GASTROENTEROLOGY,2014 Aug,28(32):11384-11393 | 2014 . 08 |
110 | 鄭隆賓(Long-Bin Jeng)*、Ashok Thorat(Ashok Thorat)、李秉純(Ping-Chun Li)、李明禮(Ming-Li Li)、楊宏仁(Horng-Ren Yang)、葉俊杰(Chun-Chieh Yeh)、陳德鴻(Te-Hong Chen)、許家豪(Chia-Hao Hsu)、許士超(Shih-Chao Hsu)、潘健成(Kin-Shing Poon),Raising-flap technique for outflow reconstruction in living donor liver transplantation,LIVER TRANSPLANTATION,2014 Apr,20(4):490-492 | 2014 . 04 |
111 | 許士超(Shih-Chao Hsu)、鄭隆賓(Long-Bin Jeng)*、Ashok Thorat(Ashok Thorat)、李秉純(Ping-Chun Li)、潘健成(Kin-Shing Poon)、許家豪(Chia-Hao Hsu)、葉俊杰(Chun-Chieh Yeh)、陳德鴻(Te-Hong Chen)、楊宏仁(Horng-Ren Yang),Management of extensive retrohepatic vena cava defect in recipients of living donor liver transplantation,TRANSPLANTATION PROCEEDINGS,2014 Apr,46(3):699-704 | 2014 . 04 |
112 | 鄭隆賓(Long-Bin Jeng)*、Ashok Thorat(Ashok Thorat)、謝右文(Yow-Wen Hsieh)、楊宏仁(Horng-Ren Yang)、葉俊杰(Chun-Chieh Yeh)、陳德鴻(Te-Hong Chen)、許士超(Shih-Chao Hsu)、許家豪(Chia-Hao Hsu),Experience of using everolimus in the early stage of living donor liver transplantation,TRANSPLANTATION PROCEEDINGS,2014 Apr,46(3):744-748 | 2014 . 04 |
113 | 張天佑、(Chin-Ying Chung)、鍾瑋敏(Wei-Min Chung)、李龍緣(Long-Yuan Li)、鄭隆賓(Long-Bin Jeng)、馬文隆(Wen-Lung Ma)*,Durable Expression of Minicircle DNA-Liposome-delivered Androgen Receptor cDNA in Mice with Hepatocellular Carcinoma,JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY,2014 Mar,2014(156356):1-9 | 2014 . 03 |
114 | 羅婉瑜(Wan-Yu Lo)、鄭隆賓(Long-Bin Jeng)、賴建成(Chien-Chen Lai)、蔡輔仁(Fuu-Jen Tsai)*、林炯璁(Chiung-Tsung Lin)、陳自諒(William Tzu-Liang Chen)*,Urinary cytidine as an adjunct biomarker to improve the diagnostic ratio for gastric cancer in Taiwanese patients,CLINICA CHIMICA ACTA,2014 Jan,428(0):57-62 | 2014 . 01 |
115 | 馬文隆(Wen-Lung Ma)*、鄭隆賓(Long-Bin Jeng)、賴學洲(Hsueh-Chou Lai)、廖佩吟(Pei-Yin Liao)、蔡秀軍(Xiujun Cai)、張傳祥(Chawnshang Chang)*,Androgen receptor enhances cell adhesion and decreases cell migration via modulating β1-integrin-AKT signaling in hepatocellular carcinoma cells,CANCER LETTERS,2014 ,351():64-71 | 2014 . |
116 | 許維儀(Wei-Yi Hsu)、陳朝榮(Chao-Jung Chen)、黃毓銓(Yu-Chuen Huang)、蔡輔仁(Fuu-Jen Tsai)、鄭隆賓(Long-Bin Jeng)*、賴建成(Chien-Chen Lai),Urinary Nucleosides as Biomarkers of Breast, Colon, Lung, and Gastric Cancer in Taiwanese,PLoS One,2013 Dec,8(12): | 2013 . 12 |
117 | 葉俊杰(Chun-Chieh Yeh)、林肇堂(Jaw-Town Lin)、鄭隆賓(Long-Bin Jeng)、(Iakovidis Charalampos)、陳姿婷(Tzu-Ting Chen)、李騰裕(Teng-Yu Lee)、吳明賢(Ming-Shiang Wu)、郭耿南(Ken N. Kuo)、劉怡雅(Yi-Ya Liu)、吳俊穎(Chun-Ying Wu)*,Hepatic resection for hepatocellular carcinoma patients on hemodialysis for uremia: a nationwide cohort study,WORLD JOURNAL OF SURGERY,2013 Oct,37(10):2402-2409 | 2013 . 10 |
118 | (Hsin-Yi Wang)、鄭隆賓(Long-Bin Jeng)、(Ming-Chia Lin)、(Chih-Hao Chao)、林萬鈺(LIN WAN-YU)、高嘉鴻(Chia-Hung Kao)*,(18)F-FDG PET/CT in detection of gynecomastia in patients with hepatocellular carcinoma.,Clinical Imaging,2013 Sep,37(5):942-946 | 2013 . 09 |
119 | 葉俊杰(Chun-Chieh Yeh)、廖建彰(CHIEN-CHANG LIAO)、(YI-CHENG CHANG)、鄭隆賓(Long-Bin Jeng)、楊宏仁(Horng-Ren Yang)、(CHUN-CHUAN SHIH)*、陳大樑(TA-LIANG CHEN),Adverse outcomes after noncardiac surgery in patients with diabetes - a nationwide population - based retrospective cohort study,DIABETES CARE,2013 Aug,36(10):3216-3221 | 2013 . 08 |
120 | 許欽木(Chin-Mu Hsu)、楊美都(Mei-Due Yang)、蔡佳紋(Chia-Wen Tsai)、何建宜(Chien-Yi Ho)、張文馨(Wen-Shin Chang)、張伸吉(Sheng-Chi Chang)、鄭隆賓(Long-Bin Jeng)、蔡育勲(Yuhsin Tsai)、蔡輔仁(Fuu-Jen Tsai)*、包大靝(Da-Tian Bau)*,The Contribution of Caveolin-1 Genotype and Phenotype to Hepatocellular Carcinoma,ANTICANCER RESEARCH,2013 Feb,33(2):671-678 | 2013 . 02 |
121 | 許欽木(Chin-Mu Hsu)、楊美都(Mei-Due Yang)、張文馨(Wen-Shin Chang)、鄭隆賓(Long-Bin Jeng)、李孟軒(Meng-Hsuan Lee)、呂孟純(Meng-Chun Lu)、張伸吉(Sheng-Chi Chang)、蔡佳紋(Chia-Wen Tsai)、蔡育勲(Yuhsin Tsai)、蔡輔仁(Fuu-Jen Tsai)*、包大靝(Da-Tian Bau)*,The Contribution of XRCC6/Ku70 to Hepatocellular Carcinoma in Taiwan,ANTICANCER RESEARCH,2013 Feb,33(2):529-536 | 2013 . 02 |
122 | 賴光啟(Kuang-Chi Lai)、鄭庚申(Ken-Sheng Cheng)、鄭隆賓(Long-Bin Jeng)、黃啟洲(Chi-Chou Huang)、(Yuan-Ti Lee)、(Horng-Rong Chang)、陳俊傑(Chun-Chieh Chen)、陳宣志(Shiuan-Chih Chen,)*、李孟智(Meng-Chih Lee),Factors associated with treatment failure of percutaneous catheter drainage for pyogenic liver abscess in patients with hepatobiliary-pancreatic cancer,AMERICAN JOURNAL OF SURGERY,2013 Jan,205(1):52-57 | 2013 . 01 |
123 | 馬文隆(Wen-Lung Ma)、鄭隆賓(Long-Bin Jeng)、葉俊杰(Chun-Chieh Yeh)、張傳祥(Chawnshang Chang)*,Androgen and androgen receptor signals jamming monocyte/macrophage functions in premalignant phase of livers,BioMedicine,2012 Sep,(): | 2012 . 09 |
124 | (Vanessa Hui-Ying Chung)、(Amy Yi-Ling Chen)、鄭隆賓(Long-Bin Jeng)、(Chang-Chin Kwan)、(Shu-Hui Cheng)、張家寧(Sophia Chia-Ning Chang)*,Engineered Autologous Bone Marrow Mesenchymal Stem Cells: an Alternative to Cleft Alveolar Bone Graft Surgery,JOURNAL OF CRANIOFACIAL SURGERY,2012 Sep,23(5):1558-1563 | 2012 . 09 |
125 | (Chun-Yi Lin)、(Jin Hua Chen)、梁基安(Ji-An Liang)、林正介(Cheng-Chieh Lin)、鄭隆賓(Long-Bin Jeng)、高嘉鴻(Chia-Hung Kao)*,18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma:A systematic review and meta-analysis,EUROPEAN JOURNAL OF RADIOLOGY,2012 Sep,81(2012):2417-2422 | 2012 . 09 |
126 | 馬文隆(Wen-Lung Ma)、徐正龍(Cheng-Lung Hsu)、葉俊杰(Chun-Chieh Yeh)、吳明恆(Ming-Heng Wu)、黃瓊葵、鄭隆賓(Long-Bin Jeng)、洪耀欽(Yao-Ching Hung)、林智一(Tze-Yi Lin)、葉淑媛(Shuyuan Yeh)、張傳祥(Chawnshang Chang)*,Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis.,HEPATOLOGY,2012 Jul,56(1):176-185 | 2012 . 07 |
127 | 李秉純(Ping-Chun Li)、鄭隆賓(Long-Bin Jeng)*、楊宏仁(Horng-Ren Yang)、李靜枝(Ching-Chih Lee)、潘健成(Kin-Shing Poon)、陳德鴻(Te-Hong Chen)、葉俊杰(Chun-Chieh Yeh)、賴學洲(Hsueh-Chou Lai)、蘇文邦(Wen-Pang Su)、彭成元(Cheng-Yuan Peng)、陳永芳(Yung-Fang Chen)、何永仁(Yung-Jen Ho),Hepatic artery reconstruction in living donor liver transplantation: running suture under surgical loupes by cardiovascular surgeons in 180 recipients,TRANSPLANTATION PROCEEDINGS,2012 Mar,44(2):448-450 | 2012 . 03 |
128 | 潘健成(Kin-Shing Poon)、鄭隆賓(Long-Bin Jeng)*、陳德鴻(Te-Hong Chen)、楊宏仁(Horng-Ren Yang)、李秉純(Ping-Chun Li)、李靜枝、葉俊杰(Chun-Chieh Yeh)、賴學洲(Hsueh-Chou Lai)、蘇文邦(Wen-Pang Su)、彭成元(Cheng-Yuan Peng)、陳永芳(Yung-Fang Chen)、何永仁(Yung-Jen Ho)、蔡伯邦(Po-Pang Tsai),A High Model for End-stage Liver Disease Score Should Not Be Considered a Contraindication to Living Donor Liver Transplantation,TRANSPLANTATION PROCEEDINGS,2012 Mar,44(1):316-319 | 2012 . 03 |
129 | 楊宏仁(Horng-Ren Yang)、鄭隆賓(Long-Bin Jeng)*、李秉純(Ping-Chun Li)、李靜枝(Ching-Chih Lee)、潘健成(Kin-Shing Poon)、陳德鴻(Te-Hong Chen)、葉俊杰(Chun-Chieh Yeh)、賴學洲(Hsueh-Chou Lai)、蘇文邦(Wen-Pang Su)、彭成元(Cheng-Yuan Peng)、陳永芳(Yung-Fang Chen)、何永仁(Yung-Jen Ho),Living Donor Right Hepatectomy With Inclusion of the Middle Hepatic Vein: Outcome in 200 Donors,TRANSPLANTATION PROCEEDINGS,2012 Mar,44(2):460-462 | 2012 . 03 |
130 | 張文馨(Wen-Shin Chan)、楊美都(Mei-Due Yang)、蔡佳紋(Chia-Wen Tsai)、(Li-Hao Cheng)、鄭隆賓(Long-Bin Jeng)、(Woei-Chung Lo)、林志學(Chih-Hsueh Lin)、黃志揚(Chih-Yang Huang)*、包大靝(Da-Tian Bau)*,Association of Cyclooxygenase 2 Single Nucleotide Polymorphisms and Hepatocellular Carcinoma in Taiwan,CHINESE JOURNAL OF PHYSIOLOGY,2012 Jan,55(1):1-7 | 2012 . 01 |
131 | 許家豪(Chia-Hao Hsu)、楊宏仁(Horng-Ren Yang)、陳德鴻(Te-Hong Chen)、鄭隆賓(Long-Bin Jeng)*、潘健成(Kin-Shing Poon)、陳永芳(Yung-Fang Chen)、葉俊杰(Chun-Chieh Yeh)*,Arterioportal Fistula as a Rare Cause of Cryptogenic Portal Hypertension,AMERICAN SURGEON,2012 ,(): | 2012 . |
132 | 蘇啟成(Khay-Seng Soh)、鄭隆賓(Long-Bin Jeng)*、楊宏仁(Horng-Ren Yang)、李秉純(Ping-Chun Li)、李靜枝(Lee Ching Chih)、潘健成(Kin-Shing Poon)、陳德鴻(Te-Hong Chen)、葉俊杰(Chun-Chieh Yeh)、賴學洲(Hsueh-Chou Lai)、蘇文邦(Wen-Pang Su)、彭成元(Cheng-Yuan Peng)、陳永芳(Yung-Fang Chen)、何永仁(Yung-Jen Ho),Simultaneous Liver and Kidney Transplantation From Different Living Donors,TRANSPLANTATION PROCEEDINGS,2012 ,44(2):509-511 | 2012 . |
133 | 林晏年(Yen-Nien Lin)、周仁偉(Jen-Wei Chou)*、鄭庚申(Ken-Sheng Cheng)*、彭成元(Cheng-Yuan Peng)、鄭隆賓(Long-Bin Jeng)、江宜平(I-Ping Chiang),Treatment of Fulminant Autoimmune Hepatitis: Corticosteroid Therapy or Liver Transplantation? A Case Report andLiterature Review,Gastroenterology Research,2011 Oct,4(5):231-235 | 2011 . 10 |
134 | 韓至強(Eric C. Han)、李英雄(Ying-shiung Lee)、劉玉晴(Yu-Ching Liu)、廖欣儀(Hsin-Yi Liao)、廖彣欣(Wen-Sin Liao)、賴學洲(Hsueh-Chou Lai)、彭成元(Cheng-Yuan Peng)*、鄭隆賓(Long-Bin Jeng),Mass spectrometry-based plasma peptide profiling of acute exacerbation in HBeAg-positive chronic hepatitis B,CLINICA CHIMICA ACTA,2011 Aug,412(23-24):2174-2182 | 2011 . 08 |
135 | 陳宗家(Tsung-Chia Chen)、林伯昌(Po-Chang Lin)、齊治宇(Chih-Yu Chi)、何承懋(Cheng-Mao Ho)、周家卉(Chia-Hui Chou)、何茂旺(Mao-Wang Ho)、王任賢(Jen-Hsien Wang)、鄭隆賓(Long-Bin Jeng),Infection in liver transplant recipients---Analysis of 68 cases at teaching hospital in Taiwan,微免與感染雜誌,2011 Aug,(): | 2011 . 08 |
136 | 許維儀(Wei-Yi Hsu)、林瑋德(Wei-De Lin)、蔡育勲(Yuhsin Tsai)、林炯璁(Chiung-Tsung Lin)、王惠暢(Hwei-Chung Wang)、鄭隆賓(Long-Bin Jeng)、賴建成(Chien-Chen Lai)*、蔡輔仁(Fuu-Jen Tsai)*,Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry,CLINICA CHIMICA ACTA,2011 Jun,412(19-20):1861-1866 | 2011 . 06 |
137 | 陳自諒(William Tzu-Liang Chen)*、張伸吉(Sheng-Chi Chang)、江驊哲(Hua-Che Chiang)、羅婉瑜(Wan-Yu Lo)、鄭隆賓(Long-Bin Jeng)、(Christina Wu)、柯道維(KE TAO-WEI)*,Single-incision laparoscopic versus conventional laparoscopic right hemicolectomy: a comparison of short-term surgical results,SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES,2011 Jun,25(6):1887-1892 | 2011 . 06 |
138 | 李龍緣(Long-Yuan Li)*、戴惠玉(Huei-Yue Dai)、(Yeh FL)、(Kan SF)、(Lang J,)、(Hsu JL)、鄭隆賓(Long-Bin Jeng)、陳雅惠(Ya-Huey Chen)、佘玉萍(Yuh-Pyng Sher)、林文川(Wen-Chuan Lin)、洪明奇(Mien-Chie Hung)*,Targeted hepatocellular carcinoma proapoptotic BikDD gene therapy,ONCOGENE,2011 Apr,30(15):1773-1783 | 2011 . 04 |
139 | 廖秀蓉(Hsiu-Rong Liao)、李聰世(Tsung-Shih Li)、陳坤堡(Kuen-Bao Chen)、李繼源(Chi-Yuan Li)、鄭隆賓(Long-Bin Jeng)、楊宏仁(Horng-Ren Yang)、潘健成(Kin-Shing Poon)*,Rare malposition of a central venous catheter into the left internal mammary vein in a liver transplantation patient,Journal of Anesthesia,2011 Apr,00540(011):1115-1116 | 2011 . 04 |
140 | 彭成元(Cheng-Yuan Peng)*、陳志濱(Chih-Bin Chen)、賴學洲(Hsueh-Chou Lai)、蘇文邦(Wen-Pang Su)、莊伯恒(Po-Heng Chuang)、吳宏達(Hong-Dar Isaac Wu)、鄭隆賓(Long-Bin Jeng),Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation.,Hepatology International,2011 Mar,5(1):586-596 | 2011 . 03 |
141 | 林君宜(Chun-Yi Lin)、林文元(Wen-Yuan Lin)、林正介(Cheng-Chieh Lin)、施純明(Chuen-Ming Shih)、鄭隆賓(Long-Bin Jeng)、高嘉鴻(Chia-Hung Kao)*,The negative impact of fatty liver on maximum standard uptake value of liver on FDG PET,Clinical Imaging,2011 Feb,35(2011):437-441 | 2011 . 02 |
142 | 韓至強(Eric C. Han)*、李英雄(Ying-shiung Lee)、廖彣欣(Wen-Sin Liao)、劉玉晴(Yu-Ching Liu)、廖欣儀(Hsin-Yi Liao)、鄭隆賓(Long-Bin Jeng)*,Direct tissue analysis by MALDI-TOF mass spectrometry in human hepatocellular carcinoma,CLINICA CHIMICA ACTA,2011 Jan,(412):230-239 | 2011 . 01 |
143 | 蔡世傳、鄭隆賓(Long-Bin Jeng)、(Jun-Jun Yeh)、林正介(Cheng-Chieh Lin)、陳錦華(Chen Jin-Hua)、林萬鈺(LIN WAN-YU)*、高嘉鴻(Chia-Hung Kao)*,Findings of 2-fluoro-2-deoxy-D: -glucose positron emission tomography in hemorrhoids,ABDOMINAL IMAGING,2011 ,(): | 2011 . |
144 | 陳宗家(Tsung-Chia Chen)、林伯昌(Po-Chang Lin)、齊治宇(Chih-Yu Chi)、何承懋(Cheng-Mao Ho)、周家卉(Chia-Hui Chou)、何茂旺(Mao-Wang Ho)*、王任賢(Jen-Hsien Wang)、鄭隆賓(Long-Bin Jeng)*,Infection in liver transplant recipients-Analysis of 68 cases at teaching hospital in Taiwan,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2011 ,(44):303-309 | 2011 . |
145 | 張家寧(Sophia Chia-Ning Chang)、鍾慧穎(Hui-Ying Chung)、(Ching-Lung Tai)、(Philip Kuo-Ting Chen)、林宗民(Tsung-Min Lin)、鄭隆賓(Long-Bin Jeng)*,Repair of Large Scale Cranium Bone Defects by hBMP-2 Expressing Bone Marrow Stromal Cells: Comparison between Alginate and Collagen Type I Systems,JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A,2010 Aug,94(2):433-441 | 2010 . 08 |
146 | 謝旻晃(Min-Huang Hsieh)、邱世欽(Shyh-Ching Chiou)*、陳清助(Ching-Chu Chen)、徐武輝(Wu-Huei Hsu)、鄭隆賓(Long-Bin Jeng)、張以承(Yi-Cheng Chang)、林仁德(Jen-Der Lin),Anatomical Asymmetry in Goiter:A Demonstration by Three-dimensional Power Doppler Ultrasound,Journal of Medical Ultrasound,2010 Mar,18(1):27-33 | 2010 . 03 |
147 | (Ju-Fang Liu)、馮逸卿(Yi-Chin Fong)、張誌祥(Chih-Shiang Chang)、黃俊寅(Chun-Yin Huang)、陳賢德(Hsien-Te Chen)、楊維宏(Wei-Hung Yang)、許晉榮(Chin-Jung Hsu)、鄭隆賓(Long-Bin Jeng)、陳志毅(Chih-Yi Chen)、湯智昕(Tang Chih-Hsin)*,Cyclooxygenase-2 enhances a2b1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells,Molecular Cancer,2010 Feb,43(9):1-14 | 2010 . 02 |
148 | 張家寧(Sophia Chia-Ning Chang)、林宗民(Tsung-Min Lin)、鍾慧穎(Hui-Ying Chung)、陳國鼎(Philip Kuo-Ting Chen)、林峰輝(Feng-Huei Lin)、樓覺人(Jeuren Lou)、鄭隆賓(Long-Bin Jeng)*,Large Scale Bicortical Cranial Bone Regeneration using Ex Vivo Replication Defective Adenoviral-Mediated BMP-2 Gene-Transferred Bone Marrow Stromal Cell and Composite biomaterials,NEUROSURGERY,2009 Dec,65(6):75-82 | 2009 . 12 |
149 | 鄭隆賓(Long-Bin Jeng)*、羅婉瑜(Wan-Yu Lo)、許維儀(Wei-Yi Hsu)、林瑋德(Wei-De Lin)、林炯璁(Chiung-Tsung Lin)、賴建成(Chien-Chen Lai)、蔡輔仁(Fuu-Jen Tsai),Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis,RAPID COMMUNICATIONS IN MASS SPECTROMETRY,2009 Jun,23(11):1543-1549 | 2009 . 06 |
150 | 許維儀(Wei-Yi Hsu)、陳自諒(William Tzu-Liang Chen)、林瑋德(Wei-De Lin)、蔡輔仁(Fuu-Jen Tsai)、蔡育勲(Yuhsin Tsai)、林炯璁(Chiung-Tsung Lin)、羅婉瑜(Wan-Yu Lo)、鄭隆賓(Long-Bin Jeng)*、賴建成(Chien-Chen Lai)*,Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry,CLINICA CHIMICA ACTA,2009 Apr,402(1-2):31-37 | 2009 . 04 |
151 | 張家寧(Sophia Chia-Ning Chang)、戴金龍(Chin-Lung Tai)、鍾慧穎(Hui-Ying Chung)、林宗民(Tsung-Min Lin)、鄭隆賓(Long-Bin Jeng)*,Bone marrow mesenchymal stem cells form ectopic woven bone in vivo through endochondral bone formation,ARTIFICIAL ORGANS,2009 Apr,33(4):301-308 | 2009 . 04 |
152 | (Shiuan-Chih Chen)、(Yuan-Ti Lee)、(Chi-Hua Yen)、賴光啟(Kuang-Chi Lai)、鄭隆賓(Long-Bin Jeng)、(Ding-Bang Lin)、(Po-Hui Wang)、(Chun-Chieh Chen)*、(Meng-Chih Lee)、(William R. Bell),Pyogenic liver abscess in the elderly: clinical features, outcomes and prognostic factors.,AGE AND AGEING,2009 Feb,(38):271-276 | 2009 . 02 |
153 | 劉俊人(Chun-Jen Liu)、李伯皇(Po-Huang Lee)、林燈寅(Deng-Yn Lin)、吳誠中(Cheng-Chung Wu)、鄭隆賓(Long-Bin Jeng)、林炳文(Pin-Wen Lin)、莫景棠(King-Tong Mok)、李威震(Wei-Chen Lee)、葉宏仁(Hong-Zen Yeh)、何明志(Ming-Chih Ho)、(Sheng-Shun Yang)、李靜枝(Ching-Chih Lee)、游明晉(Ming-Chin Yu)、胡瑞恆(Rey-Heng Hu)、彭成元(Cheng-Yuan Peng)、(Kuan-Lang Lai)、(Stanley Shi-Chung Chang)、陳培哲(Pei-Jer Chen)*,Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage,JOURNAL OF HEPATOLOGY,2009 Feb,50(5):958-968 | 2009 . 02 |
154 | 蘇文邦(Wen-Pang Su)、彭成元(Cheng-Yuan Peng)*、賴學洲(Hsueh-Chou Lai)、廖光福(Kuan-Fu Liao)、黃文信(Wen-Hsin Huang)、莊伯恒(Po-Heng Chuang)、陳志濱(Chih-Bin Chen)、鄭隆賓(Long-Bin Jeng),Persistent Transaminase Elevations in Chronic Hepatitis C Patients with Virological Response during Peginterferon and Ribavirin Therapy,HEPATO-GASTROENTEROLOGY,2009 ,(56):798-801 | 2009 . |
155 | 邱世欽(Shyh-Ching Chiou)*、謝旻晃(Min-Huang Hsieh)、陳恒瑜(H. Y. Chen)、(J. D. Lin)、陳清助(Ching-Chu Chen)、徐武輝(Wu-Huei Hsu)、鄭隆賓(Long-Bin Jeng)、張淳堆(Chwen-Tzuei Chang)、陳榮興(Rong-Hsing Chen)、王子源(Tzu-Yuan Wang)、黃偉倫(Wei-Lun Huang),The reproducibility of the virtual organ computer-aided analysis program for evaluating 3-dimensional power oppler ultrasonography of diffuse thyroid disorders,JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION,2009 ,(32):139-146 | 2009 . |
156 | 鄭隆賓(Long-Bin Jeng)、鍾慧穎(Hui-Ying Chung)、林宗民(Tsung-Min Lin)、陳志平(Jyh-Ping Chen)、陳翊綾(Yi-Ling Chen)、呂宜龍(Yi-Long Lu)、王盈錦(Yng-Jiin Wang)、張家寧(Sophia Chia-Ning Chang)*,Characterization and osteogenic effects of mesenchymal stem cells on microbeads composed of hydroxyapatite nanoparticles/reconstituted collagen,JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A,2008 Dec,91A(3):886-893 | 2008 . 12 |
157 | 陳翊綾(YL Chen)、陳國鼎(PKT Chen)、鄭隆賓(Long-Bin Jeng)、黃炯興(CS Huang)、楊寧正(LC Yang)、鍾慧穎(Hui-Ying Chung)、張家寧(Sophia Chia-Ning Chang)*,Periodontal regeneration using ex vivo autologous stem cells engineered to express the BMP-2 gene:an alternative to alveolaplasty,GENE THERAPY,2008 Nov,15(22):1469-1477 | 2008 . 11 |
158 | 賴光啟(Kuang-Chi Lai)、江宏志(Hung-Chih Chiang)、陳汶吉(Chen, Wen-Chi)、蔡輔仁(Fuu-Jen Tsai)、鄭隆賓(Long-Bin Jeng)*,Artificial Neural Network-Based Study Can Predict Gastric Cancer Staging,HEPATO-GASTROENTEROLOGY,2008 Nov,(55):1859-1863 | 2008 . 11 |
159 | 李靜枝(Ching-Chih Lee)、鄭隆賓(Long-Bin Jeng)*、潘健成(Kin-Shing Poon)、陳永芳(Yung-Fang Chen)、何永仁(Yung-Jen Ho)、賴學洲(Hsueh-Chou Lai),Fatal Duodenal Hemorrhage Complicated after Living Donor Liver Transplantation: A Case Report,TRANSPLANTATION PROCEEDINGS,2008 Oct,40(8):2840-2841 | 2008 . 10 |
160 | 劉玉成(Yu-Cheng Liu)、潘健成(Kin-Shing Poon)*、吳世銓(Rick Sai-Chuen Wu)、李靜枝(Ching-Chih Lee)、鄭隆賓(Long-Bin Jeng),Persistent dizziness and nausea in patients receiving postoperative edidural pain control after living donor liver transplantation:case reports,TRANSPLANTATION PROCEEDINGS,2008 Oct,(40):2484-8435 | 2008 . 10 |
161 | 李靜枝(Ching-Chih Lee)、鄭隆賓(Long-Bin Jeng)*、李秉純(Ping-Chun Li)、楊宏仁(Horng-Ren Yang)、盧志維(Chih-Wei Lu)、陳德鴻(Te-Hong Chen)、鄭旭棠(Hsu-Tang Cheng)、張家寧(Sophia Chia-Ning Chang)、林孟羲(Meng-Shi Lin)、潘健成(Kin-Shing Poon)、陳永芳(Yung-Fang Chen)、何永仁(Yung-Jen Ho),Innovative Technique to Reconstruct Two Branches of the Right Hepatic Artery in Living Donor Liver Transplantation,TRANSPLANTATION PROCEEDINGS,2008 Oct,40(8):2525-2526 | 2008 . 10 |
162 | 鄭隆賓(Long-Bin Jeng)*、李秉純(Ping-Chun Li)、楊美都(Mei-Due Yang)、李靜枝(Ching-Chih Lee)、張嘉麟(Jia-Lien Chang)、吳世銓(Rick Sai-Chuen Wu),Artificial Vascular Graft for Inferior Vena Cava Reconstruction in Living Donor Liver Transplantation: A Case Report,TRANSPLANTATION PROCEEDINGS,2008 Oct,40(8):2527-2528 | 2008 . 10 |
163 | 鄭隆賓(Long-Bin Jeng)*、李靜枝(Ching-Chih Lee)、江驊哲(Hua-Che Chiang)、陳德鴻(Te-Hong Chen)、許政雄(Cheng-Hsiung Hsu)、鄭旭棠(Hsu-Tang Cheng)、賴學洲(Hsueh-Chou Lai),Indication for Splenectomy in the Era of Living-Donor Liver Transplantation,TRANSPLANTATION PROCEEDINGS,2008 Oct,40(8):2531-2533 | 2008 . 10 |
164 | 陳德鴻(Te-Hong Chen)、鄭隆賓(Long-Bin Jeng)*、李靜枝(Ching-Chih Lee)、李秉純(Ping-Chun Li)、黃瑞建(Jui-Chein Huang)、許政雄(Cheng-Hsiung Hsu)、潘健成(Kin-Shing Poon)、陳永芳(Yung-Fang Chen)、何永仁(Yung-Jen Ho)、莊伯恒(Po-Heng Chuang)、賴學洲(Hsueh-Chou Lai),Polytetrafluoroethylene Patch Venoplasty for Outflow Reconstruction in Living Donor Liver Transplantation: Two Case Reports.,TRANSPLANTATION PROCEEDINGS,2008 Oct,40(8):2025-2030 | 2008 . 10 |
165 | 馮逸卿(Yi-Chin Fong)、馬明琪(Maa Ming-Chei)、蔡輔仁(Fuu-Jen Tsai)、陳汶吉(Chen Wen-Chi)、林昭庚(Jaung-Geng Lin)、鄭隆賓(Long-Bin Jeng)、楊榮森(Rong-Sen Yang)、符文美(Wen-Mei Fu)、湯智昕(Tang Chih-Hsin)*,Osteoblast-derived TGF-beta1 stimulates IL-8 release through AP-1 and NF-kappaB in human cancer cells,JOURNAL OF BONE AND MINERAL RESEARCH,2008 Jun,23(6):961-970 | 2008 . 06 |
166 | 游朝慶(Chao-Chin Yu)、楊美都(Mei-Due Yang)*、吳建廷(Chen-Teng Wu)、鄭隆賓(Long-Bin Jeng),Resection margin in preventing the intrahepatic recurrence after resection of hepatocellular carcinoma.,Formosan Journal of Surgery,2007 Nov,40(6):236-242 | 2007 . 11 |
167 | 陳宣志(Shiuan-Chih Chen)、吳唯雅(Wei-Ya Wu)、(Chung-Hsin Yeh)、賴光啟(Kuang-Chi Lai)、鄭庚申(Ken-Sheng Cheng)、鄭隆賓(Long-Bin Jeng)、王博輝(Po-Hui Wang)、林定邦(Ding-Bang Lin)、林俊傑(Chun-Chieh Chen)、李孟智(Meng-Chih Lee),Comparison of escherichia coli and klebsiella pneumoniae liver abscesses,AMERICAN JOURNAL OF THE MEDICAL SCIENCES,2007 Aug,2(334):97-105 | 2007 . 08 |
168 | 謝奇勳(Chi-Hsun Hsieh)、王毓駿(Yu-Chun Wang)、楊宏仁(Horng-Ren Yang)、鍾斌魁(Ping-Kuei Chung)、鄭隆賓(Long-Bin Jeng)、陳瑞杰(Ray-Jade Chen)*,Retroperitoneal Abscess Resulting From Perforated Acute Appendicitis: Analysis of Its Management and Outcome,SURGERY TODAY,2007 ,(37):762-767 | 2007 . |
169 | 陳志榮(CJ Chen)、鄭隆賓(Long-Bin Jeng)、黃秀芬(SF Huang)*,Lymphoepithelioma-like hepatocellular carcinoma.,Chang Gung Medical Journal,2007 ,30(2):172-177 | 2007 . |
170 | 楊宏仁(Horng-Ren Yang)、黃懷緒(Huai-Hsu Huang)、王毓駿(Yu-Chun Wang)、謝奇勳(Chi-Hsun Hsieh)、鍾斌魁(Ping-Kuei Chung)、鄭隆賓(Long-Bin Jeng),Management of Right Colon Diverticulitis: A Ten-Year Experience.,WORLD JOURNAL OF SURGERY,2006 Sep,10(30):1929-1934 | 2006 . 09 |
171 | (Poon KS)、(Fung ST)、鄭隆賓(Jeng,Long-Bin)、(Wu RS),Seizure attack during partial hepatectomy in a living donor for liver transplantation under sevoflurane anesthesia.,ACTA ANAESTHESIOLOGICA SCANDINAVICA,2006 Jun,2(44):123-126 | 2006 . 06 |
172 | 王毓駿(Yu-Chun Wang)、楊宏仁(Horng-Ren Yang)、鍾斌魁(Ping-Kuei Chung)、鄭隆賓(Long-Bin Jeng)、陳瑞杰(Ray-Jade Chen)*,Laparoscopic Appendectomy in the Elderly.,SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES,2006 Jun,(20):887-889 | 2006 . 06 |
173 | 王毓駿(Yu-Chun Wang)、楊宏仁(Horng-Ren Yang)、鍾斌魁(Ping-Kuei Chung)、鄭隆賓(Long-Bin Jeng)、陳瑞杰(Ray-Jade Chen)*,Urgent Laparoscopic Cholecystectomy in the Management of Acute Cholecystitis: Timing dose not Influence Conversion Rate,SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES,2006 May,(20):806-808 | 2006 . 05 |
174 | 王毓駿(Yu-Chun Wang)、陳瑞杰(Ray-Jade Chen)*、楊宏仁(Horng-Ren Yang)、鍾斌魁(Ping-Kuei Chung)、鄭隆賓(Long-Bin Jeng),Role of Fundus-First Laparoscopic Cholecystectomy in the Management of Acute Cholecystitis for Geriatric Patients,Journal of Laparoendoscopic & Advanced Surgical Techniques,2006 May,2(16):124-127 | 2006 . 05 |
175 | 謝奇勳(Chi-Hsun Hsieh)、王毓駿(Yu-Chun Wang)、楊宏仁(Horng-Ren Yang)、鍾斌魁(Ping-Kuei Chung)、鄭隆賓(Long-Bin Jeng)、陳瑞杰(Ray-Jade Chen)*,Extensive Retroperitoneal and Right Thigh Abscess in a Patient with Ruptured Retrocecal Appendicitis: An Extremely Fulminant Form of a Common Disease,World journal of gastroenterology : WJG,2006 Mar,3(12):496-499 | 2006 . 03 |
176 | 陳宣志(Chen SC)、李原地(Lee YT)、賴光啟(Lai, Kuang-Chi)、鄭庚申、鄭隆賓(Jeng,Long-Bin)、吳唯雅(Wu WY)、陳俊澤(Chen CC)、李孟智(Lee MC),Risk factors for developing metastatic infection from pyogenic liver abscesses.,SWISS MEDICAL WEEKLY,2006 Feb,7-8(136):119-126 | 2006 . 02 |
177 | 楊宏仁(Horng-Ren Yang)、王毓駿(Yu-Chun Wang)、鍾斌魁(Ping-Kuei Chung)、陳維恭(Wei-Kung Chen)、鄭隆賓(Long-Bin Jeng)、陳瑞杰(Ray-Jade Chen)*,Laboratory Tests in Patients with Acute Appendicitis.,ANZ JOURNAL OF SURGERY,2006 Jan,(76):71-74 | 2006 . 01 |
178 | 潘健成(Kin-Shing Poon)、馮仕端(Si-Tun Fung)、鄭隆賓(Long-Bin Jeng)、吳世銓(Rick Sai-Chuen Wu),Seizure attack during partial hepatectomy in a living donor for liver transplantation under sevoflurance anesthesia,Acta Anesthesiologica Sinica,2006 ,(44):123-126 | 2006 . |
179 | 賴光啟(Kuang-Chi Lai)、陳汶吉(Chen Wen-Chi)、蔡輔仁(Fuu-Jen Tsai)、(Li SY)、(Chou MC)、鄭隆賓(Long-Bin Jeng)*,Glutathione S-transferase M1 gene null genotype and gastric cancer risk in Taiwan.,HEPATO-GASTROENTEROLOGY,2005 Nov,52(66):1916-1919 | 2005 . 11 |
180 | 賴光啟(Lai, Kuang-Chi)、陳汶吉(Chen,Wen-Chi)、鄭隆賓(Jeng,Long-Bin)、李宣佑、周明智、蔡輔仁(Tsai,Fuu-Jen)*,Association of genetic polymorphisms of MK, IL-4, p16, p21, p53 genes and human gastric cancer in Taiwan,EUROPEAN JOURNAL OF SURGICAL ONCOLOGY,2005 Nov,(31):1135-1140 | 2005 . 11 |
181 | 楊宏仁(Horng-Ren Yang)、王毓駿(Yu-Chun Wang)、鍾斌魁(Ping-Kuei Chung)、鄭隆賓(Long-Bin Jeng)、陳瑞杰(Ray-Jade Chen)*,Laparoscopic appendectomy using the ligasure vessel sealing system,Journal of Laparoendoscopic & Advanced Surgical Techniques,2005 Aug,15(4):353-356 | 2005 . 08 |
182 | 楊宏仁(Horng-Ren Yang)、王毓駿(Yu-Chun Wang)、鍾斌魁(Ping-Kuei Chung)、陳維恭(Wei-Kung Chen)、鄭隆賓(Long-Bin Jeng)、陳瑞杰(Ray-Jade Chen)*,Role of leukocyte count, neutrophil percentage, and C-reactive protein in the diagnosis of acute appendicitis in the elderly,AMERICAN SURGEON,2005 Mar,71(4):344-347 | 2005 . 03 |
183 | (HS Chou)、(KF Lee)、(CN Yeh)*、(MF Chen)、鄭隆賓(Long-Bin Jeng),Long-term survival following resection of peritoneal implantation from hepatocellular carcinoma: a case report.,HEPATO-GASTROENTEROLOGY,2005 ,52(64):1221-1223 | 2005 . |
184 | 葉俊傑(Chun-Chieh Yeh)、李靜枝(Ching-Chih Lee)、楊美都(Mei-Due Yang)、江宜平(I-Ping Chiang)、鄭隆賓(Long-Bin Jeng)*,Hepatic inflammatory pseudotumors with portal veinthrombosis and extremely elevated-fetroprotein level,Mid-Taiwan Journal of Medicine,2005 ,10(4):225-231 | 2005 . |
185 | 陳志濱(Chih-Bin Chen)、賴學洲(Hsueh-Chou Lai)*、彭成元(Cheng-Yuan Peng)、鄭隆賓(Long-Bin Jeng)、何永仁(Yung-Jen Ho)、江宜平(I-Ping Chiang),Primary hepatic carcinoid tumor: report of a case,臺灣消化醫學雜誌,2005 ,2(22):129-135 | 2005 . |
186 | 賴光啟(Lai, Kuang-Chi)、陳汶吉(Chen,Wen-Chi)、蔡輔仁(Tsai,Fuu-Jen)、李暄佑、鄭隆賓(Jeng,Long-Bin)*,Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.,HEPATO-GASTROENTEROLOGY,2005 ,(52):944-948 | 2005 . |
187 | 陳達人(Dar Ren Chen)、(Ruey-Feng Chang)*、(Chii-Jen Chen)、(Chih-Chia Chang)、鄭隆賓(Long-Bin Jeng),Three-dimensional ultrasound in margin evaluation for breast tumor excision using mammotome.,ULTRASOUND IN MEDICINE AND BIOLOGY,2004 ,2(30):169-179 | 2004 . |
188 | (Yeh CN)、(Lee WC)、鄭隆賓(Long-Bin Jeng)、(Chen MF),Hepatic resection for hepatocellular carcinoma in elderly patients.,Hepatogastroenterology,2004 ,55(51):219-223 | 2004 . |
189 | (HP Tsai)、鄭隆賓(Long-Bin Jeng)、李威震(WC Lee)、陳敏夫(MF Chen)*,Clinical experience of hepatic hemangioma undergoing hepatic resection.,DIGESTIVE DISEASES AND SCIENCES,2003 May,48(5):916-920 | 2003 . 05 |
190 | 楊美都(Mei-Due Yang)、鄭隆賓(Long-Bin Jeng)、高嘉鴻(Chia-Hung Kao)、林正介(Cheng-Chieh Lin)、李正淳(Cheng-Chun Lee),C-Reactive Protein and Gallium Scintigraphy in Patients after Abdominal Surgery,HEPATO-GASTROENTEROLOGY,2003 Mar,50(50):354-356 | 2003 . 03 |
191 | 鄭隆賓(Long-Bin Jeng)*、李威震(WC Lee)、(CM Hung)、(MC Yu)、(LM Kuo)、陳敏夫(MF Chen),Liver transplantation in a patient with human immunodeficiency virus infection: a case report.,TRANSPLANTATION PROCEEDINGS,2003 Feb,35(1):361-361 | 2003 . 02 |
192 | (WC Lee)*、(YJ Chiang)、(HC Wang)、鄭隆賓(Long-Bin Jeng)、陳敏夫(MF Chen)、(L Lu)、(S Qian),FASL-transduced muscular cells induce apoptosis of activated T-lymphocytes.,TRANSPLANTATION PROCEEDINGS,2003 Feb,35(1):569-570 | 2003 . 02 |
193 | 鄭隆賓(Long-Bin Jeng)、(Sheng-Pin Changlai)、(Yeh-You Shen)、林正介(Cheng-Chieh Lin)、蔡長海(Chang-Hai Tsai)、高嘉鴻(Chia-Hung Kao)*,Limited Value of 18F-2-Deoxyglucose Positron Emission Tomography to Detect Hepatocellular Carcinoma in Hepatitis B Virus Carriers,HEPATO-GASTROENTEROLOGY,2003 ,50(54):2154-2156 | 2003 . |
194 | 何永仁(Yung-Jen Ho)、鄭隆賓(Long-Bin Jeng)、楊美都(Mei-Due Yang)、高嘉鴻(Chia-Hung Kao)*、林正介(Cheng-Chieh Lin)、李正淳(Cheng-Chun Lee),Usefulness of Technetium-99m Methoxyisobutylisonitrile Liver Single Photon Emission Computed Tomography to Detect Hepatocellular Carcinoma,NEOPLASMA,2003 ,50(2):117-119 | 2003 . |
195 | 陳敏夫(MF Chen)、(HP Tsai)、鄭隆賓(Long-Bin Jeng)、李威震(WC Lee)、(CN Yeh)、陳敏夫(MF Chen)*、(CM Hung),Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis.,WORLD JOURNAL OF SURGERY,2003 ,27(4):443-447 | 2003 . |
196 | 張瑞峰、吳文傑、陳達人、陳偉銘、(Wei Shu)、李昭宏(Lee,Jau-Hong)、鄭隆賓(Jeng,Long-Bin),3-D US frame positioning using speckle decorrelation and image registration,ULTRASOUND IN MEDICINE AND BIOLOGY,2003 ,6(29):801-812 | 2003 . |
197 | 陳達人(Dar-Ren Chen)、鄭隆賓(Long-Bin Jeng)、高嘉鴻(Chia-Hung Kao)*、林正介(Cheng-Chieh Lin)、李正淳(Cheng-Chun Lee),Comparing Thallium-201 Spect Mammoscintigraphy and Ultrasonography to Detect Breast Cancer in Mammographical Dense breasts,NEOPLASMA,2003 ,50(3):222-226 | 2003 . |
198 | 何永仁(Yung-Jen Ho)、鄭隆賓(Long-Bin Jeng)、楊美都(Mei-Due Yang)、高嘉鴻(Chia-Hung Kao)*、林正介(Cheng-Chieh Lin)、李正淳(Cheng-Chun Lee),A trial of single photon emission computed tomography of the liver with technetium-99m tetrofosmin to detect hepatocellular carcinoma.,ANTICANCER RESEARCH,2003 ,23(2C):1743-1746 | 2003 . |
199 | 王惠暢(Hwei-Chung Wang)、(Yu-Chien Shiau)、楊美都(Mei-Due Yang)、鄭隆賓(Long-Bin Jeng)、高嘉鴻(Chia-Hung Kao)*,The Usefulness of Technetium-99m Hexamethylpropyleneamineoxide Labeled White Blood Cell Abdomen Scan to Differentiate Periappendiceal Abscess from Acute Appendicitis- A Preliminary Report,HEPATO-GASTROENTEROLOGY,2003 ,50(50):416-418 | 2003 . |
200 | (Chen-Chang Chang)、(Chun-Yueh Tsai)、林正介(Cheng-Chieh Lin)、鄭隆賓(Long-Bin Jeng)、李正淳(Cheng-Chun Lee)、高嘉鴻(Chia-Hung Kao)*,Comparison between Technetium-99m Hexamethylpropyleneamineoxide Labeled White Blood Cell Abdomen Scan and Abdominal Sonography to Detect Appendicitis in Children with an Atypical Clinical Presentation,HEPATO-GASTROENTEROLOGY,2003 ,50(50):426-429 | 2003 . |
201 | (Dar-Ren Chen)、鄭隆賓(Long-Bin Jeng)、高嘉鴻(Chia-Hung Kao)*、林正介(Cheng-Chieh Lin)、李正淳(Cheng-Chun Lee),Usefulness of Mammoscintigraphy with Thallium-201 Single Photon Emission Computed Tomography to Differentiate Palpable Breast Masses of Young Taiwanese Women When Computing with Mammography,NEOPLASMA,2002 Oct,49(5):334-337 | 2002 . 10 |
202 | 葉俊男(CHUN-NAN YEH)*、謝奇勳(Chi-Hsun Hsieh)、洪朝明(CHAO-MING HUNG)、鄭隆賓(Long-Bin Jeng)、趙子傑(TZU-CHIEH CHAO)、陳敏夫(MIIN-FU CHEN),Acute overdoses of tacrolimus (FK 506),DIGESTIVE DISEASES AND SCIENCES,1999 Aug,44(8):1650-1652 | 1999 . 08 |
203 | 洪朝明(C.-M. Hung)*、鄭隆賓(Long-Bin Jeng)、葉俊男(C.-N. Yeh)、謝奇勳(Chi-Hsun Hsieh)、李威震(W.-C. Lee)、陳敏夫(M.-F. Chen),Tacrolimus to rescue refractory hepatic allograft rejection: a collaborative study in Taiwan,TRANSPLANTATION PROCEEDINGS,1998 Nov,30(7):3589-3589 | 1998 . 11 |
研討會論文
研討會論文/Conference Papers (發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目) |
日期 | |
1 | Comparing Curative Salvage Options for Recurrent Hepatocellular Carcinoma post Primary Liver Resection: A Nationwide Retrospective Cohort Study,衛生福利部癌症研究計畫2023年成果發表會暨國際研討會:新冠肺炎後疫情時代的癌症治療-新策略與新科技,張榮發基金會801會議室 (台北市中正區中山南路11號),2023.12.09~2023.12.09, | 2023 . 12 |
2 | Natural-compound-derived multifunctional nanomedicines for cancer theranostics,ISOMRM 2023年第六屆台灣國際再生醫學材料應用研討會,新北市淡水福容大飯店-淡水漁人碼頭舉辦,2023.08.31~2023.09.03, | 2023 . 08 |
3 | Comparative Outcomes of Curative Salvage Treatments for Recurrent Hepatocellular Carcinoma after Primary Liver Resection – a Nationwide Cohort Study,肝癌轉譯研究國際研討會,陽明交通大學守仁樓膺才廳,2023.08.27~2023.08.27, | 2023 . 08 |
4 | Inherently therapeutic fucoidan-based nanoparticles: from combination immunotherapy and advanced cell delivery to translational medicine,2023臺灣奈米生醫學會年會暨國際研討會,台中長榮桂冠酒店,2023.07.21~2023.07.22, | 2023 . 07 |
5 | 心臟死後器官捐贈之分肝移植,112年度外科聯合學術演講會,高雄醫學大學附設醫院,2023.03.18~2023.03.19, | 2023 . 03 |
6 | ,臺灣醫學會春季學術演講會,中國醫藥大學,2021.05.15~2021.05.16,外泌體在心肌衰竭的最新應用 | 2021 . 05 |
7 | Fluid restriction will not decrease urine output during living donor liver transplantation,第64屆台彎麻醉醫學會年會暨學術硏討會,高雄醫學大學,2020.09.19~2020.09.20, | 2020 . 09 |
8 | 以胃穿孔為最初表徵之胃癌-案例討論,台灣外科學會109年度外科聯合學術演講會,因嚴重特殊傳染性肺炎(COVID-19)疫情取消現場演講,2020.03.14~2020.03.15, | 2020 . 03 |
9 | ,Preceptorship Program in Living Donor Liver Transplantation China Medical University Hospital,中國醫藥大學附設醫院安康教學大樓 5樓會議室,2019.06.24~2019.06.27,Viral Hepatitis & LDLT | 2019 . 06 |
10 | Laparoscopic precise hepatectomy guided by the middle hepatic vein,The 2nd world congress of the international laparoscopic liver society,Tokyo,2019.05.09~2019.05.11, | 2019 . 05 |
11 | The Role of MTHFR Genotype in Colorectal Cancer Susceptibility in Taiwan,第34屆生物醫學聯合學術年會,國防醫學院,2019.03.23~2019.03.24, | 2019 . 03 |
12 | The Effects of ADAMTS5 Overexpression in Anti-Cisplatin Gastric Cancer Cells,第34屆生物醫學聯合學術年會,國防醫學院,2019.03.23~2019.03.24, | 2019 . 03 |
13 | 急性肝臟衰竭合併第四級肝腦病變患者接受活體肝臟移植⼿術後之預後:,台灣外科醫學會第78次學術演講會,國防醫學院,2019.03.16~2019.03.17, | 2019 . 03 |
14 | The Novel Genotype-Phenotype Correlation of Mir-146a for Liver Cancer Cells,第34屆生物醫學聯合學術年會,國防醫學院,2019.03.23~2019.03.24, | 2019 . 03 |
15 | Fenofibrate induced PPAR-α expression was attenuated by ER-α overexpression in Hep3B cells,106學年度研發日暨中亞聯大合作學術研討會,亞洲大學,2018.06.14~2018.06.14, | 2018 . 06 |
16 | The Contribution of Matrix Metalloproteinase-1 Genotypes to Hepatocellular Carcinoma Susceptibility in Taiwan,33屆生物醫學聯合學術年會,國防醫學院,2018.03.24~2018.03.25, | 2018 . 03 |
17 | Contribution of Matrix Metalloproteinases-1 Genotypes to Gastric Cancer Susceptibility in Taiwan,33屆生物醫學聯合學術年會,國防醫學院,2018.03.24~2018.03.25, | 2018 . 03 |
18 | Preoperative Volume Prediction in Adult Right Lobe Living Donor Liver Transplantation: Is There Any Improvement?,一○七年度第二十九屆第三次會員大會暨第六十七次學術研討會,台北國際會議中心(台北市信義區信義路五段1號),2018.03.24~2018.03.25, | 2018 . 03 |
19 | ,中國醫藥大學附設醫院肝友健康講座計劃,中國醫藥大學-立夫教學大樓第下一樓國際會議室,2017.12.02~2017.12.02,肝病三部曲認識B、C肝炎 | 2017 . 12 |
20 | ,11th International Minimal Invasive Surgery Symposium and 7th CME Course of the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO),Seoul,2017.06.30~2017.07.01,Laparoscopic hepatectomy Experience of 436 patients in China Medical University Hospital | 2017 . 06 |
21 | ,保肝․回甘 肝友健康講座,癌症中心一樓階梯教室,2016.12.10~2016.12.10,肝癌三部曲 認識B、C肝 | 2016 . 12 |
22 | ,保肝․回甘 肝友健康講座,中國醫藥大學附設醫院癌症中心大樓1樓 階梯教室,2016.12.10~2016.12.10,保肝大作戰 (一):肝癌內科治療 | 2016 . 12 |
23 | ,"肝"味人生--肝癌治療健康講座,中國醫藥大學附設醫院研癌症中心大樓一樓階梯教室,2016.08.13~2016.08.13,肝病-- 痛苦誰人知 | 2016 . 08 |
24 | ,Preceptorship Program in Living Donor Liver Transplantation China Medical University Hospital,兒童醫院 11樓會議室 Conference Room, 11F, Children’s Hospital,2016.04.11~2016.04.11,Chronic hepatitis B and C indication for liver transplant: treatment before and after liver transplantation | 2016 . 04 |
25 | Sorafenib For Advanced Stage HCC : Real Life Practice Analysis in Single Medical Center,中華民國一○五年消化系聯合學術演講年會,臺北榮民總醫院致德樓第三會議室,2016.03.26~2016.03.27, | 2016 . 03 |
26 | 肝臟移植在治療體染色體顯性多囊性腎臟病合併多囊性肝病變 – 二病例報告Living Donor Liver Transplantation in Autosomal-Dominant Polycystic Kidney Disease with Hepatic Involvement – Case Reports,105年度外科聯合學術演講會,台大醫學院,2016.03.19~2016.03.20, | 2016 . 03 |
27 | DNA double-strand break repair gene XRCC7 genotypes were associated with hepatocellular carcinoma risk in Taiwanese male and alcohol drinkers,第31屆生物醫學聯合學術研討會,國防醫學院,2016.03.26~2016.03.27, | 2016 . 03 |
28 | Chronic hepatitis B and C indication for liver transplant: treatment before and after liver transplantation,新加坡中央醫院學術交流參訪,兒童醫院11樓會議室,2016.03.21~2016.03.24,Viral hepatitis & LDLT | 2016 . 03 |
29 | Tumor necrosis factor-α genotypes are associated with hepatocellular carcinoma risk in Taiwanese males, smokers and alcohol drinkers,第31屆生物醫學聯合學術研討會,國防醫學院,2016.03.26~2016.03.27, | 2016 . 03 |
30 | Androgen receptor expression reduces post-hepatectomy surgery recurrence risks of hepatocellular carcinoma,AACR Annual Meeting 2015,Philadelphia, PA,2015.04.18~2015.04.22, | 2015 . 04 |
31 | Hepatectomy for A Huge Functional Pheochromocytoma With Liver Invasion : A Case Report,104年度外科聯合學術演講會,台大醫學院,2015.03.21~2015.03.22, | 2015 . 03 |
32 | Living Donor Liver Transplantation combined with Abdominal Wall Reconstruction for Hepatocellular Carcinoma with Needle Track Seeding,104年度外科聯合學術演講會,台大醫學院,2015.03.21~2015.03.22, | 2015 . 03 |
33 | ,2014中區外科月會,署立豐原醫院,2014.11.15~2014.11.15,在胃癌病人中骨頭增生的表現 | 2014 . 11 |
34 | Sorafenib Combined with Transarterial Chemoembolization or Radiation Therapy Versus Sorafenib Alone For Advanced Stage Hepatocellular Carcinoma –A Daily Practice Analysis,8th Annual Conference of the International Liver Cancer Association (ILCA), 2014,Hotel Granvia Kyoto in Japan,2014.09.05~2014.09.07, | 2014 . 09 |
35 | To Investigate the Role of XRCC6/Ku70 in Taiwanese Hepatocellular Carcinoma at DNA, RNA, and Protein Levels,第29屆生物醫學聯合學術研討會,國防醫學院,2014.03.15~2014.03.16, | 2014 . 03 |
36 | Living Donor Liver Transplantation as Salvage Treatment for Graft Failure after Decreased Donor Liver Transplantation,2014台灣外科醫學會,台北榮民總醫院,2014.03.15~2014.03.16, | 2014 . 03 |
37 | To Examine the Role of Caveolin-1 in Taiwanese Hepatocellular Carcinoma at DNA, RNA, and Protein Levels,第29屆生物醫學聯合學術研討會,國防醫學院,2014.03.15~2014.03.16, | 2014 . 03 |
38 | Androgen Receptor Immobilizes Cells and Promotes Anoikis of Hepatoma Cells to Prevent Recurrence,ISREC Synposium 2014, Cancer Metastatic Colonization(micro-environments, mechanisms,and therapeutic),Crans-Montana, Switzerland,2014.01.22~2014.01.25, | 2014 . 01 |
39 | Laparoscopic hepatectomy perliminary experience of 100 patients in China Medical University Hospital,2013 亞太內視鏡醫學會,台北國際會議中心,2013.11.22~2013.11.24, | 2013 . 11 |
40 | Comparison between TDX and QMS assay for whole blood everolimus concentration assay - using samples from LDLT recipients,the 13th Congress of the Asian Society of Transplantation,Kyoto, Japan,2013.09.02~2013.09.06, | 2013 . 09 |
41 | The experience of everolomus used in the early stage after living donor liver,CAST2013,Kyoto,Japan,2013.09.02~2013.09.06, | 2013 . 09 |
42 | Management of extensive retrohepatic vena cava defect in recipients of living donor liver transplantation,The 2013 Asian Society of Transplantation Congress,Kyoto,2013.08.30~2013.09.03, | 2013 . 08 |
43 | Retrohepatic vena cava reconstruction with temporary portocaval shunt in recipient of living donor liver transplantation,2013台灣外科醫學會,台北榮民總醫院,2013.03.16~2013.03.17, | 2013 . 03 |
44 | ,Liver Cancer Meeting,University of Heidelberg, Heidelberg, German,2012.07.04~2012.07.08,Hepatic Androgen Receptor Suppresses Hepatocellular Carcinoma Metastasis Through Modulation of Cell Invasion and Anoikis | 2012 . 07 |
45 | Case Challange:normocytic anemia, thrombocytopenia, intermittent localized RUQ pain to a 55 year-old male married bank employee,2011台灣肝癌醫學會教育研討會,臺北市立聯合醫院仁愛院區檢驗大樓6F,2011.12.03~2011.12.03, | 2011 . 12 |
46 | Arterialization of the Portal Vein for Hepatic Artery Thrombosis in Living Donor Liver Transplantation: a Case Report,2011 12th Congress of The Asian Society of Transplantation,COEX,Seoul, Korea,2011.09.25~2011.09.28, | 2011 . 09 |
47 | ,Congress of the Asian Society of Transplantation 1,Seoul,2011.09.25~2011.09.28, | 2011 . 09 |
48 | Simultaneous Liver and Kidney Transplantation From Different Living Donors,2011 12th Congress of The Asian Society of Transplantation,COEX,Seoul, Korea,2011.09.25~2011.09.28, | 2011 . 09 |
49 | Arterialization of the Portal Vein for Hepatic Artery Thrombosis in Living Donor Liver Transplantation: a Case Report,外科醫學會年會,台北醫學大學,2011.03.19~2011.03.20, | 2011 . 03 |
50 | Reconstruction of Isolated Right Hepatic Artery Injury with Right Gastroepiploic Artery After Laparoscopic Cholecystectomy,外科醫學會年會,台北醫學大學,2011.03.19~2011.03.20, | 2011 . 03 |
51 | ABO-Incompatible Living Donor Liver Transplantation: CMUH Experience,外科醫學會年會,台北醫學大學,2011.03.19~2011.03.20, | 2011 . 03 |
52 | Targeted hepatocellular carcinoma proapoptotic BikDD gene therapy,第26屆生物醫學聯合學術年會,台北,2011.03.19~2011.03.20, | 2011 . 03 |
53 | Long Term Bone Regeneration by Engineered Mesenchymal Stem Cells,5th World Congress on Preventive & Regenerative Medicine,Hannover, Germany,2010.10.05~2010.10.07, | 2010 . 10 |
54 | Transesophageal Echocardiography In Living Donor Liver Transplantation,2010台灣麻醉醫學會年會暨學術研討會,台北三軍總醫院,2010.09.18~2010.09.19, | 2010 . 09 |
55 | Maintenance of Hepatocellular Functions In Vitro Coculture with Mesenchymal Stem Cells,TERMIS 2nd World Congress,Seoul, Korea,2009.08.31~2009.09.03, | 2009 . 08 |
56 | Mesenchymal Stem Cell Therapy Ameliorates Acute Liver Injury in Rabbits,TERMIS 2nd World Congress,Seoul, Korea,2009.08.31~2009.09.03, | 2009 . 08 |
57 | The Reproducibility of the VOCAL Program for Evaluating 3D Power Doppler Ultrasonography of Thyroid Nodules,12th World congress of the World Federation for Ultrasound in Medicine and Biology,澳洲雪梨,2009.08.30~2009.09.03, | 2009 . 08 |
58 | Bone marrow mesenchymal stem cells rescue hepatic functions by reducing fibrosis in an acute liver injury mode,第七屆國際幹細胞研究組織年會,西班牙巴塞隆納國際會議中心,2009.07.08~2009.07.11, | 2009 . 07 |
59 | Cutaneous Aspergillosis in liver transplantation (LT) recipient: a case report,Focus 19 on Fungal infections,Sanibel Harbour Fort Myers, Florida,2009.03.04~2009.03.06, | 2009 . 03 |
60 | Painless jaundice with one liver tumor and satellite nodules and portal vein thrombus,肝癌醫學會中部地區研討會,中山醫學大學口腔醫學大樓,2009.02.21~2009.02.21,Painless jaundice with one liver tumor and satellite nodules and portal vein thrombus (HCC Case Challenge) | 2009 . 02 |
61 | The Reproducibility of the VOCAL Program for Evaluating 3D Power Doppler Ultrasonography of Parathyroid Glands Preliminary Reports,5th Huaxia Congress of Endocrinology,圓山大飯店,2008.12.04~2008.12.09, | 2008 . 12 |
62 | The Reproducibility of VOCAL Program for Evaluating 3D Power Doppler Ultrasonography of Diffuse Thyroid Disorders,5th Huaxia Congress of Endocrinology,圓山大飯店,2008.12.04~2008.12.09, | 2008 . 12 |
63 | ,中國醫藥大學暨附設醫院與交通大會學術合作暨研討會,中國醫藥大學附設醫院立夫醫療大樓21樓國際會議廳,2008.12.27~2008.12.27,將生命徵象傳回醫院及可攜式腹膜透析機 | 2008 . 12 |
64 | Bone Marrow Stromal Cells Recuperate Hepatocyte Functions in an acute liver injury model,Biostar 2008,Stuttgart, Garmany,2008.10.09~2008.10.11, | 2008 . 10 |
65 | Periodontal regeneration of maxilla alveolar bony defect repaired with BMP-2 gene engineered autologus bone marrow mesenchymals,Biostar 2008,Stuttgart, Garmany,2008.10.09~2008.10.11, | 2008 . 10 |
66 | Human Mesenchymal Stem Cells Expressing CD105 after ex vivo Replication Defective Adenovirus BMP-2 Mediated Gene Transfer,Biostar 2008,Stuttgart, Garmany,2008.10.09~2008.10.11, | 2008 . 10 |
67 | Comparisons between sources of Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord and bone marrow,Biostar 2008,Stuttgart, Garmany,2008.10.09~2008.10.11, | 2008 . 10 |
68 | Comparisons Between sources of Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord and bone marrow,TERMIS-EU 2008 Meeting,Porto Congress Centre-Alfandega, Portugal,2008.06.22~2008.06.26, | 2008 . 06 |
69 | Bone Marrow Stromal Cells Recuperate Hepatocyte Functions in an acute liver injury model,TERMIS-EU 2008 MEETING,PORTO, PORTUGAL,2008.06.22~2008.06.26, | 2008 . 06 |
70 | Human Bone Marrow Mesenchymal Stem Cells Expressing CD105 After Ex vivo Replication Defective Adenovirus BMP-2 Mediated Gene Therapy,TERMIS-EU 2008 Meeting,Porto Congress Centre-Alfandega, Portugal,2008.06.22~2008.06.26, | 2008 . 06 |
71 | Periodontal Regeneration Using Autologous Bone Marrow Mesenchymal Stem Cells Engineered to Express the BMP-2 Gene: An Alternative to Alveolar Bone Graft Surgery,九十七年度外科聯合學術演講會,高雄榮民總醫院,2008.03.29~2008.03.30, | 2008 . 03 |
72 | Management of Appendiceal Stump in Laparoscopic Appendectomy,九十七年度外科聯合學術演講會,高雄/高雄榮民總醫院,2008.03.29~2008.03.29, | 2008 . 03 |
73 | 藉由共同培養模式探討骨髓基質細胞分化成肝細胞及其功能之維持,台灣小兒外科醫學會第42次學術演講會暨97年度外科聯合學術演講會,高雄榮民總醫院,2008.03.29~2008.03.29, | 2008 . 03 |
74 | Emergent living donor liver transplantation for fulminant hepatic failure of adult onset still's disease.,The 10th congress of asian society of transplantation (10th CAST),Thailand, Pattaya,2007.12.01~2007.12.04, | 2007 . 12 |
75 | Gortex patch venoplasty for outflow reconstruction in living donor liver transplantation.,The 10th congress of asian society of transplantation (10th CAST),Thailand, Pattaya,2007.12.01~2007.12.04, | 2007 . 12 |
76 | Fatal duodenal hemorrhage complicated after living donor liver transplantation.,The 10th congress of asian society of transplantation (10th CAST),Thailand, Pattaya,2007.12.01~2007.12.04, | 2007 . 12 |
77 | Persistent dizziness in patients receiving postoperative epidural pain control after right lobe hepatectomy for living donor transplantation,10 th Congress of Asian Society of Transplantation (CAST),in Pattaya, Thailand,2007.12.01~2007.12.04, | 2007 . 12 |
78 | Is plasma exchange necessary in abo-incompatible living donor liver transplantation.,The 10th congress of asian society of transplantation (10th CAST),Thailand, Pattaya,2007.12.01~2007.12.04, | 2007 . 12 |
79 | Innovative technique to reconstruct two branches of right hepatic artery in living donor liver transplantation.,The 10th congress of asian society of transplantation (10th CAST),Thailand, Pattaya,2007.12.01~2007.12.04, | 2007 . 12 |
80 | 十二指腸胰臟切除手術併發症的探討與文獻回顧,台灣外科醫學會12月中部地區學術討論會,本院11B會議室,2007.12.21~2007.12.21,十二指腸胰臟切除手術併發症的探討與文獻回顧 | 2007 . 12 |
81 | The mesenchymal stem cells/collagen-hydroxyapatite microsphere constructs for craniofacial bone repair — comparison between the nanoparticle and microparticle,5th International Society for Stem Cell Research Annual Meeting,Cairns Convention Centre, Cairns, Queensland, Australia,2007.06.17~2006.06.20, | 2007 . 06 |
82 | HUMAN BONE MARROW MESENCHYMAL STEM CELLS EXPRESSING ENDOBLIN AFTER EX VIVO REPLICATION DEFECTIVE ADENOVIRUS BMP-2 MEDIATED GENE TRANSFER,5th International Society for Stem Cell Research Annual Meeting,Cairns Convention Centre, Cairns, Queensland, Australia,2007.06.17~2007.06.20, | 2007 . 06 |
83 | Differentiation into hepatocytes and maintenance of hepatocyte functions by coculture with bone marrow stromal cells,5th International Society for Stem Cell Research Annual Meeting,Cairns Convention Centre, Cairns, Queensland, Australia,2007.06.17~2007.06.20, | 2007 . 06 |
84 | Periodontal regeneration of mandibular alveolar bony defect repaired with bmp-2 gene engineered autologus bone marrow mesenchymal stem cells,5th International Society for Stem Cell Research Annual Meeting,Cairns Convention Centre, Cairns, Queensland, Australia,2007.06.17~2007.06.20, | 2007 . 06 |
85 | Adenoid cystic carcinoma of breast: case report,台灣外科醫學會96年度會員大會暨學術演講會,台灣高雄,2007.03~ , | 2007 . 03 |
86 | Studies on the Collagen-Hydroxyapatite microsphere /Mesenchymal Stem Cells Constructs for Craniofacial Bone Repair--- Comparison of Microparticle and Nanoparticle,96年外科醫學會,高雄榮總,2007.03.24~2007.03.25, | 2007 . 03 |
87 | Anaplastic thyroid carcinoma: a case report,台灣外科醫學會96年度會員大會暨學術演講會,台灣高雄,2007.03~ , | 2007 . 03 |
88 | Studies on the Collagen-Hydroxyapatite microsphere/mesenchymal stem cells constructs for craniofacial bone repair: comparison of microparticle and nanoparticle,台灣外科醫學會96年度會員大會暨學術演講會,台灣高雄,2007.03~ , | 2007 . 03 |
89 | Microarray analysis of hbv-related early human hepatocellular carcinoma,2006年台灣消化系醫學會秋季會,台灣台北市,2006.09~ , | 2006 . 09 |
90 | Autologus mesenchymal cell may be the vehicle for ex vivo gene therapy –the long term tissue engineered bone. ,4th International Society for Stem Cell Research,加拿大多倫多,2006.06~ , | 2006 . 06 |
91 | Autologus mesenchymal cell may be the vehicle for ex vivo gene therapy–the long term tissue engineered bone,4th International Society for Stem Cell Research,加拿大 多倫多,2006.06.29~2006.07.01, | 2006 . 06 |
92 | The application of 3-d ultrasonography in diffuse goiters,11th congress of the world federation for ultrasound in medicine and biology,韓國首爾,2006.05~ , | 2006 . 05 |
93 | Case Report:Image Finding of Left Sided Appendicitis in Patient with Midgut Malrotation and Horseshoe Kidney,第二十屆第一次會員代表大會暨第65次學術演講會,台灣林口長庚大學,2006.03~ , | 2006 . 03 |
94 | Gastric cancer with isolated colorectal metastasis: report of a case,台灣外科醫學會第65次學術演講會,台灣桃園,2006.03~ , | 2006 . 03 |
95 | ,台灣外科醫學會第65次學術演講會,桃園林口長庚醫院,2006.03.25~2006.03.26, | 2006 . 03 |
96 | The application of 3-d ultrasonography in diffuse goiters,中華民國內分泌暨糖尿病學會第九屆第三次會員大會暨學術演講會,台灣台北市,2006.03~ , | 2006 . 03 |
97 | 3-D超音波影像在甲狀腺腫大的研究,中華民國內分泌暨糖尿病學會第九屆第三次會員大會暨學術演講會,台北榮民總醫院,2006.03.25~2006.03.26, | 2006 . 03 |
98 | Analysis of Clinicopathological Factors and Prognosis of Gastrointestinal Stromal Tumor,第二十屆第一次會員代表大會暨第65次學術演講會,台灣林口長庚大學,2006.03~ , | 2006 . 03 |
99 | Integrating Emergency General Surgery with A Trauma Surgeon Viability ?,第二十屆第一次會員代表大會暨第65次學術演講會,台灣林口長庚大學,2006.03~ , | 2006 . 03 |
100 | Analysis of Causes of Trauma Deaths in the Emergency Department of CMUH.,第二十屆第一次會員代表大會暨第65次學術演講會,台灣林口長庚大學,2006.03~ , | 2006 . 03 |
101 | Recombinant factor VIIa used as an adjunctive method of hemostasis management in pelvic fracture patients after massive transfusion and transcatheter arterial embolization.,8th Novo Nordisk Symposium on Haemostasis Management,丹麥,2005.05~ , | 2005 . 05 |
102 | Non-transplant therapy for HELLP syndrome related acute hepatic failure: a case report,台灣外科醫學會第19屆第2次會員代表大會暨第64次學術演講會,台灣桃園,2005.03~ , | 2005 . 03 |
103 | Thalidomide related Toxic epidermal necrosis in a patient with advanced hepatocellular carcinoma,台灣外科醫學會第19屆第2次會員代表大會暨第64次學術演講會,台灣桃園,2005.03~ , | 2005 . 03 |
104 | Effects of Tamoxifen on DNA adduct formation and arylamines N-acetyltransferase activity in human breast cancer cells,台灣外科醫學會第19屆第2次會員代表大會暨第64次學術演講會,台灣桃園,2005.03~ , | 2005 . 03 |
105 | Small intestinal stromal tumors,台灣外科醫學會第64次學術演講會,台灣桃園,2005.03~ , | 2005 . 03 |
106 | Posttransplant eosinophilic gastroenteritis in adult: a case report,台灣外科醫學會第19屆第2次會員代表大會暨第64次學術演講會,台灣桃園,2005.03~ , | 2005 . 03 |
107 | Management of right colonic diverticulitis: 10 years' experience,台灣外科醫學會第19屆第2次會員代表大會暨第64次學術演講會,台灣桃園,2005.03~ , | 2005 . 03 |
108 | Hemoperitoneum from a spontaneously reptured rectal stromal tumor,台灣外科醫學會第19屆第2次會員代表大會暨第64次學術演講會,台灣桃園,2005.03~ , | 2005 . 03 |
109 | The effectiveness of current protocol to prevent HBV reinfection after liver transplantation,台灣外科醫學會第19屆第2次會員代表大會暨第64次學術演講會,台灣桃園,2005.03~ , | 2005 . 03 |
110 | Risk factors of recurrence after curative resection for hepatocellular carcinoma,台灣外科醫學會第19屆第2次會員代表大會暨第64次學術演講會,台灣桃園,2005.03~ , | 2005 . 03 |
111 | Small intestinal stromal tumors,台灣外科醫學會第19屆第2次會員代表大會暨第64次學術演講會,台灣桃園,2005.03~ , | 2005 . 03 |
112 | Incarcerated diaphragmatic hernia after right lobectomy for hepatocellular carcinoma: cases report,台灣外科醫學會第19屆第2次會員代表大會暨第64次學術演講會,台灣桃園,2005.03~ , | 2005 . 03 |
113 | Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer,台灣外科醫學會年會,台灣台北,2004.03~ , | 2004 . 03 |
114 | A rare case: pediatric penile lymphoma,台灣外科醫學會年會,台灣台北,2004.03~ , | 2004 . 03 |
115 | Primary stromal sarcoma of breast: case report,台灣外科醫學會年會,台灣台北,2004.03~ , | 2004 . 03 |
116 | The experience of Taiwanese patients underwent liver transplantation at mainland's hospital,台灣外科醫學會年會,台灣台北,2004.03~ , | 2004 . 03 |
117 | 使用健保資料庫分析臺灣地區嚴重墜落傷害病患治療之危險因子(2000~2001),九十三年度外科聯合學術演講會,臺灣台北,2004.03~ , | 2004 . 03 |
118 | Inflammatory hepatice pseudotumor with elevated α-fetoprotein: a case report,台灣外科醫學會年會,台灣台北,2004.03~ , | 2004 . 03 |
119 | A modified method for minimally invasive Video-assisted thyroidectomy: the CMUH experience,台灣外科醫學會年會,台灣台北,2004.03~ , | 2004 . 03 |
120 | Personal experience in sonographically guided directional vacuum-assisted breast biopsy,92年度台灣外科醫學會年會,台灣台北,2003.03~ , | 2003 . 03 |
121 | Perforated NEC in ELBW: experience in CMCH,92年度台灣外科醫學會年會,台灣台北,2003.03~ , | 2003 . 03 |
122 | Reversible cerebral hypoperfusion observed with Tc-99m on ECD SPECT in reversible dementia caused by postthyroidectomy hypothyroidism,92年度台灣外科醫學會年會,台灣台北,2003.03~ , | 2003 . 03 |
專書
專書/Books (作者,書名,出版商,出版日期) |
日期 | |
1 | 鄭隆賓(Long-Bin Jeng)、江易穎(Yi-Ying Chiang),ICU急症醫學(The ICU Book 3/e),合記,2009.1 | 2009 . 01 |
研究計畫
研究計畫/Research Grant (研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,計畫期間) |
日期 | |
1 | 個別型,CMU113-ASIA-13,鄭隆賓(Long-Bin Jeng)、詹雯玲(Wen-Ling Chan),本校(含附醫),利用次世代定序技術分析部分肝切除手術小鼠與病人血清檢體發展非侵入性肝癌復發生物標記之平台,2024.8.1~2025.7.31 | 2024 . 08 |
2 | 個別型,NSTC 113-2124-M-039-005,鄭隆賓(Long-Bin Jeng)、徐偉成(Woei-Cheang Shyu),科技部,雙特異性奈米載體用於原位且即時的內源性癌症疫苗(1/2),2024.8.1~2025.7.31 | 2024 . 08 |
3 | 個別型,DMR-HHC-113-12,鄭隆賓(Long-Bin Jeng)、王約翰(John Wang),本校(含附醫),整合免疫組織化學染色和次世代基因定序方法偵測B型肝炎病毒Pre-S2突變蛋白以發展一個增強的預後系統更好地預測根治性手術切除後的肝癌復發,2024.6.1~2025.5.31 | 2024 . 06 |
4 | 個別型,MOHW113-TDU-B-212-114009,蔡輔仁(Fuu-Jen Tsai)、李光申(Oscar Kuang-Sheng Lee)、白禮源(Li-Yuan Bai)、鄭隆賓(Long-Bin Jeng)、蔡崇豪(Chon-Haw Tsai),衛福部,113年臨床試驗新型態卓越計畫-臨床試驗中心計畫,2024.1.1~2024.12.31 | 2024 . 01 |
5 | 個別型,DMR-113-028,鄧喬方(Teng,Chiao-Fang),本校(含附醫),利用缺氧處理的肝癌細胞裂解物做為抗原製備一種新穎的樹突狀細胞疫苗誘發增強的T細胞抗腫瘤免疫反應用以治療肝癌 (I),2023.8.1~2024.7.31 | 2023 . 08 |
6 | 個別型,CMU112-ASIA-06,鄭隆賓(Long-Bin Jeng)、詹雯玲(Wen-Ling Chan),本校(含附醫),利用次世代定序技術分析胞外小體微型核糖核酸做為B型肝炎病毒相關肝癌復發生物標記之平台,2023.8.1~2024.7.31 | 2023 . 08 |
7 | 個別型,DMR-113-149,鄭隆賓(Long-Bin Jeng)、徐偉成(Woei-Cheang Shyu)、許士超(Shih-Chao Hsu),附醫院內計畫,探索共享新抗原用於開發具有專一性及有效性之新抗原標靶免疫療法以治療肝細胞癌,2023.8.1~2024.7.31 | 2023 . 08 |
8 | 個別型,DMR-113-027,鄧喬方(Teng,Chiao-Fang)、鄭隆賓(Long-Bin Jeng),附醫院內計畫,利用表現B型肝炎病毒Pre-S2突變蛋白之肝癌細胞裂解物負載之樹突狀細胞疫苗合併PD-1/PD-L1免疫檢查點抑制劑發展一種新穎的免疫療法用以治療肝癌,2023.8.1~2024.7.31 | 2023 . 08 |
9 | 個別型,DMR-113-062,鄧喬方(Teng,Chiao-Fang)、鄭隆賓(Long-Bin Jeng),本校(含附醫),利用部分肝臟切除手術之小鼠模型探討微型核糖核酸在殘留肝臟與血清胞外體中扮演的致癌角色與分子機制且評估其做為根治性切除手術後肝癌復發之非侵入性生物標記與治療標靶的潛力 (I),2023.8.1~2024.7.31 | 2023 . 08 |
10 | 個別型,MOHW112-TDU-B-212-144004,蔡輔仁(Fuu-Jen Tsai)、陳明豐(Ming-Fong Chen)、李光申(Oscar Kuang-Sheng Lee)、白禮源(Li-Yuan Bai)、徐偉成(Woei-Cheang Shyu)、鄭隆賓(Long-Bin Jeng)、蔡崇豪(Chon-Haw Tsai),衛福部,112年推動臨床試驗發展計畫,2023.1.1~2023.12.31 | 2023 . 01 |
11 | 整合型(召集人、總主持人),NSTC 112-2823-8-039-003,徐偉成(Woei-Cheang Shyu)、鄭隆賓(Long-Bin Jeng),科技部,開發標靶腫瘤之 INSP精準藥物傳遞技術,2023.1.1~2023.12.31 | 2023 . 01 |
12 | 個別型,DMR-112-034,鄧喬方(Chiao-Fang Teng),附醫院內計畫,探討樹突狀細胞在B型肝炎病毒Pre-S2突變蛋白陽性之肝癌病人腫瘤組織中的浸潤與活性概況,2022.8.1~2023.7.31 | 2022 . 08 |
13 | 個別型,CMU111-ASIA-08,鄭隆賓(Long-Bin Jeng)、詹雯玲(Wen-Ling Chan),本校(含附醫),利用部分肝臟切除手術之動物模型結合臨床檢體篩選B型肝炎病毒相關肝癌復發生物標記之平台,2022.8.1~2023.7.31 | 2022 . 08 |
14 | 個別型,DMR-112-075,鄧喬方(Chiao-Fang Teng)、鄭隆賓(Long-Bin Jeng),附醫院內計畫,探索殘留肝臟中異常調控之微型核糖核酸做為切除手術後B型肝炎病毒相關肝癌復發之生物標記與治療標靶,2022.8.1~2023.7.31 | 2022 . 08 |
15 | 個別型,DMR-112-157,鄭隆賓(Long-Bin Jeng)、黃升騰(Sheng-Teng Huang)、林宏任(Hung-jen Lin)、賴香君(Hsiang-Chun Lai)、歐世宸(Shi-Chen Ou)、林橙莉(Cheng-Li Lin),附醫院內計畫,肝移植患者因抗排斥藥導致腎衰竭而接受中西醫合併照護之成果分析,2022.8.1~2023.6.30 | 2022 . 08 |
16 | 個別型,MOST 111-2823-8-039-002,鄭隆賓(Long-Bin Jeng)、徐偉成(Woei-Cheang Shyu),科技部,科研創業計畫:開發標靶三陰性乳癌之新型藥物包覆技術平台,2022.1.1~2022.12.31 | 2022 . 01 |
17 | 個別型,MOHW111-TDU-B-212-134004,蔡輔仁(Fuu-Jen Tsai)、陳明豐(Ming-Fong Chen)、周德陽(Der-Yang Cho)、李光申(Oscar Kuang-Sheng Lee)、白禮源(Li-Yuan Bai)、徐偉成(Woei-Cheang Shyu)、鄭隆賓(Long-Bin Jeng)、蔡崇豪(Chon-Haw Tsai),衛福部,111年推動臨床試驗發展計畫,2022.1.1~2022.12.31 | 2022 . 01 |
18 | 個別型,DMR-111-046,鄧喬方(Chiao-Fang Teng),附醫院內計畫,探討骨髓來源抑制細胞在B型肝炎病毒Pre-S2突變蛋白陽性之肝癌組織中的浸潤與活性,2021.8.1~2022.7.31 | 2021 . 08 |
19 | 個別型,DMR-111-047,鄧喬方(Chiao-Fang Teng)、鄭隆賓(Long-Bin Jeng),附醫院內計畫,使用人類初代肝臟細胞培養系統探討胞外小體在B型肝炎病毒相關肝癌致病機轉中扮演的角色,2021.8.1~2022.7.31 | 2021 . 08 |
20 | 個別型,DMR-111-092,鄧喬方(Chiao-Fang Teng)、鄭隆賓(Long-Bin Jeng),附醫院內計畫,探討微型核糖核酸在B型肝炎病毒Pre-S2突變蛋白陽性肝癌病人的肝臟組織和血液胞外體中的表現概況,2021.8.1~2022.7.31 | 2021 . 08 |
21 | 個別型,MOHW110-TDU-B-212-124004,蔡輔仁(Fuu-Jen Tsai)、陳明豐(Ming-Fong Chen)、周德陽(Der-Yang Cho)、李光申(Oscar Kuang-Sheng Lee)、白禮源(Li-Yuan Bai)、徐偉成(Woei-Cheang Shyu)、鄭隆賓(Long-Bin Jeng)、蔡崇豪(Chon-Haw Tsai),衛福部,推動臨床試驗發展計畫,2021.1.1~2021.12.31 | 2021 . 01 |
22 | 個別型,CMU109-ASIA-09,鄭隆賓(Long-Bin Jeng)、詹雯玲(Wen-Ling Chan),本校(含附醫),利用次世代定序技術偵測血漿中B型肝炎病毒Pre-S基因突變並預測切除手術後肝癌復發之平台,2020.8.1~2021.7.31 | 2020 . 08 |
23 | 個別型,DMR-110-043,鄧喬方(Chiao-Fang Teng),附醫院內計畫,探討腫瘤相關纖維母細胞在B型肝炎病毒Pre-S2突變蛋白陽性之肝癌組織中的浸潤與活性,2020.8.1~2021.7.31 | 2020 . 08 |
24 | 個別型,MOHW109-TDU-B-212-114004,林昭庚(Jaung-Geng Lin)、蔡輔仁(Fuu-Jen Tsai)、趙坤山(Kun-San Chao)、陳明豐(Ming-Fong Chen)、周德陽(Der-Yang Cho)、張建國(Jan-Gowth Chang)、白禮源(Li-Yuan Bai)、張恒鴻(Hen-Hong Chang)、藍先元(Hsien-Yuan Lane)、徐偉成(Woei-Cheang Shyu)、鄭隆賓(Long-Bin Jeng)、蔡崇豪(Chon-Haw Tsai),衛福部,109年推動臨床試驗發展計畫,2020.1.1~2020.12.31 | 2020 . 01 |
25 | 個別型,DMR-109-072,鄧喬方(Chiao-Fang Teng)、鄭隆賓(Long-Bin Jeng),附醫院內計畫,結合腫瘤細胞裂解物負載之樹突狀細胞和免疫檢查點抑制劑發展有效治療肝癌的疫苗,2019.8.1~2020.7.31 | 2019 . 08 |
26 | 個別型,DMR-109-033,鄧喬方(Chiao-Fang Teng)、徐偉成(Woei-Cheang Shyu),附醫院內計畫,結合熱療、樹突狀細胞活化以及免疫檢查點抑制發展多功能奈米藥物用以治療肝癌,2019.8.1~2020.7.31 | 2019 . 08 |
27 | 個別型,CMU107-N-09,鄭隆賓(Long-Bin Jeng)、徐偉成(Woei-Cheang Shyu),本校(含附醫),探索B型肝炎病毒Pre-S2突變蛋白異常調控之微型核糖核酸及其在肝癌生成與復發上扮演的角色,2018.11.7~2019.7.31 | 2018 . 11 |
28 | 個別型,DMR-108-033,鄧喬方(Chiao-Fang Teng),附醫院內計畫,探討免疫檢查點分子在B型肝炎病毒Pre-S2突變蛋白陽性之肝癌組織中的表現情形,2018.8.1~2019.7.31 | 2018 . 08 |
29 | 個別型,MOST 107-2320-B-039-053-,鄭隆賓(Long-Bin Jeng)、徐偉成(Woei-Cheang Shyu),科技部,探索新穎的胞外小體之預後生物標記與標靶用以治療肝切除和移植後之肝癌復發,2018.8.1~2019.7.31 | 2018 . 08 |
30 | 個別型,MOST 105-2320-B-039-066-MY2,鄭隆賓(Jeng, Long-Bin)、徐偉成(Shyu, Woei-Cherng),科技部,結合B型肝炎病毒Pre-S2突變蛋白負載之樹突狀細胞和抑制性腫瘤趨向胞外體發展有效治療肝癌的疫苗,2017.11.1~2018.7.31 | 2017 . 11 |
31 | 個別型,DMR-107-148,鄭隆賓(Jeng, Long-Bin)、徐偉成(Shyu, Woei-Cherng),附醫院內計畫,B型肝炎病毒Pre-S2突變蛋白誘發之胞外體異常機轉可做為肝癌診斷的生物標記與肝癌治療的分子標靶,2017.8.1~2018.6.30 | 2017 . 08 |
32 | 個別型,DMR-107-034,鄧喬方(Teng, Chiao-Fang),附醫院內計畫,探討腫瘤浸潤淋巴細胞在B型肝炎病毒Pre-S2突變蛋白陽性之肝癌組織中的分布情形,2017.8.1~2018.7.31 | 2017 . 08 |
33 | 臨床試驗與研究計畫,CMUH102-REC1-053,,附醫廠商計畫,一項多中心、隨機分配、開放性、第三期試驗,針對患有無法切除之肝細胞癌的受試者,比較Lenvatinib與Sorafenib作為第一線治療的療效與安全性,2017.1.1~2017.12.31 | 2017 . 01 |
34 | 臨床試驗與研究計畫,CMUH102-REC1-127,莊伯恒(Po-Heng Chuang)、陳永芳(Chen, Yung-Fang)、彭成元(Peng, Cheng-Yuan)、楊宏仁(Yang, Horng-Ren),附醫廠商計畫,第三期、安慰劑對照、多國多中心、隨機分配、雙盲試驗,評估K-333 (peretinoin)用於亞洲肝癌完全治癒受試者之療效及安全性,2017.1.1~2017.12.31 | 2017 . 01 |
35 | 個別型,MOST 105-2320-B-039-066-MY2,鄭隆賓(Jeng, Long-Bin)、徐偉成(Shyu, Woei-Cherng),科技部,結合B型肝炎病毒Pre-S2突變蛋白負載之樹突狀細胞和抑制性腫瘤趨向胞外體發展有效治療肝癌的疫苗,2016.11.1~2017.10.31 | 2016 . 11 |
36 | 臨床試驗與研究計畫,DMR98-IRB-091,,附醫廠商計畫,一項隨機分配、雙盲、多中心的第 Ⅲ 階段臨床試驗,針對患有晚期肝細胞癌(HCC)但對Sorafenib 治療失敗或不耐受的受試者,施以Brivanib 加上最佳支持性照護(BSC)與安慰劑加上最佳支持性 照護(BSC)之比較:BRISK PS 研究,2016.1.1~2016.12.31 | 2016 . 01 |
37 | 臨床試驗與研究計畫,DMR100-IRB-141,,附醫廠商計畫,以PI-88作為肝炎病毒相關之肝癌術後輔助療法之前瞻性、隨機、雙盲、安慰劑對照、平行分組、國際多中心第三期臨床試驗。,2016.1.1~2016.12.31 | 2016 . 01 |
38 | 臨床試驗與研究計畫,CMUH102-REC1-050,,附醫廠商計畫,比較ADI PEG 20配合最佳支持性照護(BSC)與安慰劑配合BSC於已接受全身性治療而無效的晚期肝細胞癌(HCC)患者之隨機、雙盲、多中心第三期臨床試驗,2016.1.1~2016.12.31 | 2016 . 01 |
39 | 臨床試驗與研究計畫,DMR99-IRB-060,,附醫廠商計畫,一項隨機分配、第3期、雙盲、安慰劑對照、多中心試驗,針對sorafenib治療失敗的後期肝細胞癌成人病患評估everolimus (RAD001)療效和安全性-EVOLVE-1試驗,2016.1.1~2016.12.31 | 2016 . 01 |
40 | 臨床試驗與研究計畫,CMUH102-REC1-127,莊伯恒(Po-Heng Chuang)、陳永芳(Yung-Fang Chen)、彭成元(Cheng-Yuan Peng)、楊宏仁(Horng-Ren Yang),附醫廠商計畫,第三期、安慰劑對照、多國多中心、隨機分配、雙盲試驗,評估K-333 (peretinoin)用於亞洲肝癌完全治癒受試者之療效及安全性,2016.1.1~2016.12.31 | 2016 . 01 |
41 | 臨床試驗與研究計畫,DMR98-IRB-257,,附醫廠商計畫,比較Linifanib(ABT-869)與Sorafenib對晚期肝細胞癌(HCC)病患的療效及耐受性之開放型,隨機,第三期試驗,2016.1.1~2016.12.31 | 2016 . 01 |
42 | 臨床試驗與研究計畫,DMR98-IRB-109,,附醫廠商計畫,一項隨機分配、雙盲、多中心的第三期臨床研究,對於患有晚期肝細胞癌之病患,以Brivanib或Sorafenib作為第一線治療之比較(BRISK FL研究),2016.1.1~2016.12.31 | 2016 . 01 |
43 | 臨床試驗與研究計畫,DMR98-IRB-139,,附醫廠商計畫,一項隨機分配、雙盲、多中心的第Ⅲ期試驗,以Bivanib相對於安慰劑作為經動脈化療栓塞術(TACE)之輔助療法,用於無法藉由手術切除肝細胞癌之病患:BRISK TA 試驗。,2016.1.1~2016.12.31 | 2016 . 01 |
44 | 臨床試驗與研究計畫,CMUH103-REC1-001,,附醫廠商計畫,一項開放標示、單一組別、兩階段、多中心第二期臨床試驗,以評估TLC388做為晚期肝細胞癌病患第二線治療的療效與安全性,2016.1.1~2016.12.31 | 2016 . 01 |
45 | 臨床試驗與研究計畫,CMUH102-REC1-053,,附醫廠商計畫,一項多中心、隨機分配、開放性、第三期試驗,針對患有無法切除之肝細胞癌的受試者,比較Lenvatinib與Sorafenib作為第一線治療的療效與安全性,2016.1.1~2016.12.31 | 2016 . 01 |
46 | 臨床試驗與研究計畫,DMR99-IRB-084,,附醫廠商計畫,一項臨床第四期、單組、開放性試驗,評估sorafenib (Nexavar蕾莎瓦®)使用於晚期肝細胞腫瘤(肝癌)患者,2016.1.1~2016.12.31 | 2016 . 01 |
47 | 臨床試驗與研究計畫,CMUH103-REC2-028,陳永芳(Yung-Fang Chen)、彭成元(Cheng-Yuan Peng)、莊伯恒(Po-Heng Chuang)、賴學洲(Hsueh-Chou Lai),附醫廠商計畫,比較ADI PEG 20合併經導管動脈化學藥物栓塞治療(TACE)與單純經動脈化學栓塞治療於無法手術切除肝細胞癌(HCC)患者之隨機、開放式第二期臨床試驗。,2016.1.1~2016.12.31 | 2016 . 01 |
48 | 臨床試驗與研究計畫,CMUH103-REC1-092,楊宏仁(Horng-Ren Yang)、賴學洲(Hsueh-Chou Lai)、蘇文邦(Wen-Pang Su),附醫廠商計畫,一項為期 24 個月、隨機分配對照試驗,評估濃度控制之 everolimus 加上減量之 tacrolimus,相較於標準劑量之 tacrolimus,用於活體肝臟移植患者之療效與安全性。,2016.1.1~2016.12.31 | 2016 . 01 |
49 | 臨床試驗與研究計畫,DMR98-IRB-092,,附醫廠商計畫,以隨機開放標示比較多中心之試驗評估Prograf®/Myfotic與Advagraft®/Myfotic使用於首次肝臟移植患者之安全性及有效性,2016.1.1~2016.12.31 | 2016 . 01 |
50 | 臨床試驗與研究計畫,DMR101-IRB2-296,,附醫廠商計畫,Sorafenib 長期延伸計畫(STEP),2016.1.1~2016.12.31 | 2016 . 01 |
51 | 個別型,NSC101-2314-B-039-027-MY3,鄭隆賓(Long-Bin Jeng),科技部,血液裡癌細胞之男性荷爾蒙受體對於在癌復發/ 轉移之相關研究—以肝癌為例,2014.8.1~2015.7.31 | 2014 . 08 |
52 | 個別型,NSC101-2314-B-039-027-MY3,鄭隆賓(Long-Bin Jeng),科技部,血液裡癌細胞之男性荷爾蒙受體對於在癌復發/ 轉移之相關研究—以肝癌為例,2013.8.1~2014.7.31 | 2013 . 08 |
53 | 個別型,DMR-103-105,鄭隆賓(Long-Bin Jeng)、李珮端(Pei Dawn Lee Chao)、侯鈺琪(Hou YuChi),附醫院內計畫,薑黃對口服everolimus之療效影響-藥物動力學研究,2013.8.1~2014.7.31 | 2013 . 08 |
54 | 個別型,NSC101-2314-B-039-027-MY3,鄭隆賓(Long-Bin Jeng),科技部,血液裡癌細胞之男性荷爾蒙受體對於在癌復發/ 轉移之相關研究—以肝癌為例,2012.8.1~2013.7.31 | 2012 . 08 |
55 | 個別型,NSC100-2314-B-039-001-MY2,鄭隆賓(Long-Bin Jeng),科技部,男性荷爾蒙受體對於血液裡肝癌細胞在癌轉移的影響,2011.8.1~2012.7.31 | 2011 . 08 |
56 | 產學合作,09842720,楊美都(Mei-Due Yang)、彭成元(Cheng-Yuan Peng)、鄭庚申(Ken-Sheng Cheng)、楊宏仁(Horng-Ren Yang)、蘇文邦(Wen-Pang Su)、高榮達(Jung-Ta Kao)、莊伯恒(Po-Heng Chuang)、賴學洲(Hsueh-Chou Lai)、陳永芳(Yung-Fang Chen),附醫廠商計畫,一項隨機分配、雙盲、多中心的第三期臨床研究,對於患者晚期肝細胞癌之病患,以BRIVANIB或SORAFENIB作為第一線治療之比較(BRISK FL研究)』,2011.7.1~2012.5.31 | 2011 . 07 |
57 | 個別型,NSC100-2314-B-039-001-MY1,鄭隆賓(Long-Bin Jeng),科技部,男性荷爾蒙受體對於血液裡肝癌細胞在癌轉移的影響,2011.1.1~2011.7.31 | 2011 . 01 |
58 | 產學合作,09842721,楊美都(Mei-Due Yang)、彭成元(Cheng-Yuan Peng)、鄭庚申(Ken-Sheng Cheng)、楊宏仁(Horng-Ren Yang)、蘇文邦(Wen-Pang Su)、高榮達(Jung-Ta Kao)、莊伯恒(Po-Heng Chuang)、賴學洲(Hsueh-Chou Lai)、陳永芳(Yung-Fang Chen),附醫廠商計畫,一項隨機分配、雙盲、多中心的第三期臨床研究,對於患者有晚期肝細胞癌(HCC)但對SORAFENIB治療失敗或不耐受的受試者,施以BRIVANIB加上最佳支持行照顧(BSC)與安慰劑加上最佳支持性照護(BSC)之比較:BRISK PS,2010.9.1~2011.8.31 | 2010 . 09 |
59 | 個別型,DMR-100-037,張家寧(Sophia Chia-Ning Chang),附醫院內計畫,由人類骨髓中胚層幹細胞及傳遞成骨蛋白-2,二者加成可加強抗癌的功效,2010.8.1~2011.7.31 | 2010 . 08 |
60 | 個別型,DMR-100-159,鄭隆賓(Long-Bin Jeng)、張傳祥,附醫院內計畫,男性賀爾蒙受體對於血液裡肝癌細胞在癌轉移的影響,2010.8.1~2011.6.30 | 2010 . 08 |
61 | 產學合作,09842720,楊美都(Mei-Due Yang)、彭成元(Cheng-Yuan Peng)、鄭庚申(Ken-Sheng Cheng)、楊宏仁(Horng-Ren Yang)、蘇文邦(Wen-Pang Su)、高榮達(Jung-Ta Kao)、莊伯恒(Po-Heng Chuang)、賴學洲(Hsueh-Chou Lai)、陳永芳(Yung-Fang Chen),附醫廠商計畫,一項隨機分配、雙盲、多中心的第三期臨床研究,對於患者晚期肝細胞癌之病患,以BRIVANIB或SORAFENIB作為第一線治療之比較(BRISK FL研究)』,2010.7.1~2011.6.30 | 2010 . 07 |
62 | 產學合作,099427B1,楊宏仁(Horng-Ren Yang)、楊美都(Mei-Due Yang)、莊伯恒(Po-Heng Chuang)、彭成元(Cheng-Yuan Peng)、蘇文邦(Wen-Pang Su)、賴學洲(Hsueh-Chou Lai)、鄭庚申(Ken-Sheng Cheng)、高榮達(Jung-Ta Kao)、陳永芳(Yung-Fang Chen)、陳德鴻(Te-Hong Chen),附醫廠商計畫,一項臨床第四期、單組、開放性試驗,評估sorafenib(Nexavar蕾莎瓦R)使用於晚期肝細胞腫瘤(肝癌)患者,2010.6.30~2011.6.29 | 2010 . 06 |
63 | 產學合作,09842753,楊宏仁(Horng-Ren Yang)、楊美都(Mei-Due Yang)、莊伯恒(Po-Heng Chuang)、彭成元(Cheng-Yuan Peng)、蘇文邦(Wen-Pang Su)、賴學洲(Hsueh-Chou Lai)、鄭庚申(Ken-Sheng Cheng)、高榮達(Jung-Ta Kao)、陳永芳(Yung-Fang Chen),附醫廠商計畫,比較 LINIFANIB(ABT-869)與SPORAFENIB 對晚期肝細胞癌(HCC)病患的療效及耐受性之開放型,隨機,第三期試驗,2009.12.30~2010.12.29 | 2009 . 12 |
64 | 產學合作,09842721,楊美都(Mei-Due Yang)、彭成元(Cheng-Yuan Peng)、鄭庚申(Ken-Sheng Cheng)、楊宏仁(Horng-Ren Yang)、蘇文邦(Wen-Pang Su)、高榮達(Jung-Ta Kao)、莊伯恒(Po-Heng Chuang)、賴學洲(Hsueh-Chou Lai)、陳永芳(Yung-Fang Chen),附醫廠商計畫,一項隨機分配、雙盲、多中心的第三期臨床研究,對於患者有晚期肝細胞癌(HCC)但對SORAFENIB治療失敗或不耐受的受試者,施以BRIVANIB加上最佳支持行照顧(BSC)與安慰劑加上最佳支持性照護(BSC)之比較:BRISK PS,2009.9.1~2010.8.31 | 2009 . 09 |
65 | 產學合作,09842731,楊美都(Mei-Due Yang)、彭成元(Cheng-Yuan Peng)、鄭庚申(Ken-Sheng Cheng)、楊宏仁(Horng-Ren Yang)、蘇文邦(Wen-Pang Su)、高榮達(Jung-Ta Kao)、莊伯恒(Po-Heng Chuang)、賴學洲(Hsueh-Chou Lai)、陳永芳(Yung-Fang Chen),附醫廠商計畫,一項隨機分配、雙盲、多中心的第III期試驗,以BIVANIB相對於安慰劑作為經動脈化療栓塞術(TACE)之輔助療法,用於無法藉由手術切除肝細胞癌之病患:BRISK TA 試驗,2009.8.13~2010.8.12 | 2009 . 08 |
66 | 產學合作,09842720,楊美都(Mei-Due Yang)、彭成元(Cheng-Yuan Peng)、鄭庚申(Ken-Sheng Cheng)、楊宏仁(Horng-Ren Yang)、蘇文邦(Wen-Pang Su)、高榮達(Jung-Ta Kao)、莊伯恒(Po-Heng Chuang)、賴學洲(Hsueh-Chou Lai)、陳永芳(Yung-Fang Chen),附醫廠商計畫,一項隨機分配、雙盲、多中心的第三期臨床研究,對於患者晚期肝細胞癌之病患,以BRIVANIB或SORAFENIB作為第一線治療之比較(BRISK FL研究)』,2009.7.1~2010.6.30 | 2009 . 07 |
67 | 產學合作,09742708,楊宏仁(Horng-Ren Yang)、李靜枝,附醫廠商計畫,以隨機、開放標示、比較、多中心之試驗,評估Prograf/Myfortic與Advagraf/Myfortic使用於首次肝臟移植患者之安全性及有效性,2009.7.1~2010.6.30 | 2009 . 07 |
68 | 個別型,DMR-98-114,鄭隆賓(Long-Bin Jeng)、趙小慧(Hsiao-Huei Chao),附醫院內計畫,藉由共同培養模式探討骨髓間葉細胞分化成肝細胞及其功能之維持,2009.1.7~2009.12.31 | 2009 . 01 |
69 | 個別型,DMR-98-136,張家寧(Sophia Chia-Ning Chang)、鄭隆賓(Long-Bin Jeng),附醫院內計畫,藉由共同培養模式探討骨髓閒葉細胞分化成肝細胞及其功能之維持,2008.8.1~2009.7.31 | 2008 . 08 |
70 | 個別型,DOH96-TD-M-113-040,鄭隆賓(Long-Bin Jeng)、陳維恭(Wei-Kung Chen)、陳世堅(Chen,Shih Chien)、邱怡玟,衛福部,捐贈器官移植分配原則之研究,2007.3.1~2008.2.29 | 2007 . 03 |
71 | 個別型,CMU95-134,張家寧(Sophia Chia-Ning Chang),本校(含附醫),蛋白質體的探討:看骨髓間質細胞在肝修腹的潛能,2006.8.1~2007.7.31 | 2006 . 08 |
72 | 個別型,DMR-96-043,賴光啟(Kuang-Chi Lai)、陳汶吉(Chen, Wen-Chi)、林維勇(Wei-Yong Lin)、蔡輔仁(Fuu-Jen Tsai)、鄭隆賓(Long-Bin Jeng)、丁文謙(Wen-Chien Ting),附醫院內計畫,第二期大腸直腸癌術後兩年內再發與否之蛋白質差異性分析,2006.7.1~2007.6.30 | 2006 . 07 |
73 | 個別型,DMR-96-044,陳汶吉(Chen, Wen-Chi)、林維勇(Wei-Yong Lin)、蔡輔仁(Fuu-Jen Tsai)、鄭隆賓(Long-Bin Jeng)、丁文謙(Wen-Chien Ting)、陳自諒(William Tzu-Liang Chen),附醫院內計畫,以果蠅為實驗動物模式的遺傳性大腸癌抗癌藥物篩檢實驗,2006.7.1~2007.6.30 | 2006 . 07 |
74 | 個別型,DOH-BHP-95-01,彭慶添(Peng,Ching-Tien)、鄭隆賓(Jeng,Long-Bin)、吳錫金(Wu,His-Chin)、邱昌芳(Chiu,Chang-Fang)、許南榮(Hsu,Nan-Yung)、蔡銘修(Tsai,Ming-Hsui)、張兆祥(Chang,Chao-Hsian)、周德陽(Cho,Der-Yang)、夏德椿(Hsia,Te-Chun)、洪耀欽,衛福部,95-96年度安寧共同照護計畫,2006.1.1~2007.12.31 | 2006 . 01 |
75 | 個別型,CMU95-134,,,蛋白質體的探討:看骨髓間質細胞在肝修腹的潛能,2005.8.1~2006.7.31 | 2005 . 08 |
76 | 個別型,DOH-BHP-94-03,彭慶添(Peng,Ching-Tien)、鄭隆賓(Jeng,Long-Bin)、陳志毅、吳錫金(Wu,His-Chin)、邱昌芳(Chiu,Chang-Fang)、許南榮(Hsu,Nan-Yung)、蔡銘修(Tsai,Ming-Hsui)、張兆祥(Chang,Chao-Hsian)、周德陽(Cho,Der-Yang)、夏德椿(Hsia,Te-Chun),衛福部,九十四年度安寧共同照護計畫,2005.1.1~2005.12.31 | 2005 . 01 |
專利技術
專利/Patent (專利名稱,專利類別,專利國別,專利號碼,專利期間) |
日期 | |
1 | 用於治療和預防 SARS-CoV-2 病毒感染的草藥組合物,發明專利,台灣、美洲,I830493,2024.1.21~2042.11.10 | 2024 . 01 |
2 | 一種針具回收數量計算裝置,新型專利,台灣,M644752,2023.8.11~2032.12.6 | 2023 . 08 |
3 | 新穎誘導性多能幹細胞(IPSCS)及其應用,發明專利,台灣,I769410,2022.7.1~2039.10.27 | 2022 . 07 |
4 | ANTIBODY SPECIFIC TO ERYTHROPOIETIN-PRODUCING HEPATOCELLULARCARCINOMA RECEPTOR A10 AND USES THEREOF,發明專利,美國,63/264,378,2021.11.22~2023.5.21 | 2021 . 11 |
5 | MULTI-SPECIFIC ANTIBODY AND USES THEREOF,發明專利,美洲,G4590-14600,2021.10.21~2022.10.21 | 2021 . 10 |
6 | 免疫磁性组成物及其制备方法、用途和治疗癌症的试剂盒,發明專利,中國大陸,CN108785668,2018.1.16~2038.1.15 | 2018 . 01 |
獲獎事蹟
獲獎/Award (獲獎名稱,給獎單位,獲獎日期) |
日期 | |
1 | 第二十屆國家新創獎 臨床新創獎,財團法人生技醫療科技政策研究中心,2023.12.27 | 2023 . 12 |
2 | 第二十屆國家新創獎 學研新創獎,社團法人國家生技醫療科技政策研究中心,2023.12.27 | 2023 . 12 |
3 | 2023年度國家新創精進獎,社團法人國家生技醫療政策研究中心,2023.12.25 | 2023 . 12 |
4 | 第二十屆國家新創獎 精準醫學-基因修飾之間質幹細胞的外泌體治療腦中風,財團法人生技醫療科技政策研究中心,2023.10.27 | 2023 . 10 |
5 | 2023國家新創獎-學研新創獎 - 開發EphA10 三特異性抗體銜接免疫細胞藥物治療實體癌,,2023.10.27 | 2023 . 10 |
6 | 第十九屆國家新創獎 臨床新創獎,財團法人生技醫療科技政策研究中心,2022.12.3 | 2022 . 12 |
7 | 第十九屆國家新創獎:學研新創獎,生策會,2022.12.3 | 2022 . 12 |
8 | 第19屆國家新創獎,,2022.12.1 | 2022 . 12 |
9 | 第17屆國家新創獎-學研新創獎,財團法人生技醫療科技政策研究中心,2020.9.25 | 2020 . 09 |
10 | 2020未來科技獎,科技部,2020.8.27 | 2020 . 08 |
技術轉移
技術轉移/Technology Transfer (技術名稱,發明人,合約期間,專利名稱,授權單位,授權單位名稱) |
日期 | |
1 | 衍生自基因工程化之間質幹細胞的外泌體及其應用,鄭隆賓(Long-Bin Jeng)、徐偉成(Woei-Cheang Shyu)、洪明奇(Mien-Chie Hung)、林瑄翎(LIN SYUAN-LING)、陳建霖,2023.8~2043.8,,本校(含附醫),聖安生醫股份有限公司 | 2023 . 08 |
2 | 利用腫瘤高表現抗原EphA10開發免疫標靶治療平台,鄭隆賓(Long-Bin Jeng)、劉詩平(Shih-Ping Liu)、王啟鴻(Wang, Chie-Hong),2022.8~2042.8,,本校(含附醫),聖安生醫股份有限公司 | 2022 . 08 |
3 | 幹細胞應用技術,徐偉成(Woei-Cherng Shyu)、許重義(Chung Y. Hsu)、周德陽(Der-Yang Cho)、林振寰(Chen-Huan Lin)、李瑋(WEI LEE)、陳三元(San- Yuan Chen)、鄭隆賓(Long-Bin Jeng)、蔡長海(Chang-Hai Tsai),2016.7~2036.7,幹細胞應用技術,本校(含附醫),長新生醫國際股份有限公司 | 2016 . 07 |